id	sid	tid	token	lemma	pos
dti-2532	1	1	dti	dti	PROPN
dti-2532	1	2	drug	drug	PROPN
dti-2532	1	3	target	target	NOUN
dti-2532	1	4	insights	insight	NOUN
dti-2532	1	5	2022	2022	NUM
dti-2532	1	6	;	;	PUNCT
dti-2532	1	7	16	16	NUM
dti-2532	1	8	:	:	SYM
dti-2532	1	9	78	78	NUM
dti-2532	1	10	-	-	SYM
dti-2532	1	11	80	80	NUM
dti-2532	1	12	issn	issn	PROPN
dti-2532	1	13	1177	1177	NUM
dti-2532	1	14	-	-	SYM
dti-2532	1	15	3928	3928	NUM
dti-2532	1	16	|	|	ADV
dti-2532	1	17	doi	doi	NOUN
dti-2532	1	18	:	:	PUNCT
dti-2532	1	19	10.33393	10.33393	NUM
dti-2532	1	20	/	/	SYM
dti-2532	1	21	dti.2022.2532	dti.2022.2532	NUM
dti-2532	1	22	short	short	ADJ
dti-2532	1	23	communication	communication	NOUN
dti-2532	1	24	drug	drug	NOUN
dti-2532	1	25	target	target	NOUN
dti-2532	1	26	insights	insight	NOUN
dti-2532	1	27	issn	issn	VERB
dti-2532	1	28	1177	1177	NUM
dti-2532	1	29	-	-	SYM
dti-2532	1	30	3928	3928	NUM
dti-2532	1	31	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2532	1	32	©	©	PROPN
dti-2532	1	33	2022	2022	NUM
dti-2532	1	34	the	the	DET
dti-2532	1	35	authors	author	NOUN
dti-2532	1	36	.	.	PUNCT
dti-2532	2	1	this	this	DET
dti-2532	2	2	article	article	NOUN
dti-2532	2	3	is	be	AUX
dti-2532	2	4	published	publish	VERB
dti-2532	2	5	by	by	ADP
dti-2532	2	6	aboutscience	aboutscience	NOUN
dti-2532	2	7	and	and	CCONJ
dti-2532	2	8	licensed	license	VERB
dti-2532	2	9	under	under	ADP
dti-2532	2	10	creative	creative	ADJ
dti-2532	2	11	commons	common	NOUN
dti-2532	2	12	attribution	attribution	NOUN
dti-2532	2	13	-	-	PUNCT
dti-2532	2	14	noncommercial	noncommercial	ADJ
dti-2532	2	15	4.0	4.0	NUM
dti-2532	2	16	international	international	NOUN
dti-2532	2	17	(	(	PUNCT
dti-2532	2	18	cc	cc	NOUN
dti-2532	2	19	by	by	ADP
dti-2532	2	20	-	-	PUNCT
dti-2532	2	21	nc	nc	PROPN
dti-2532	2	22	4.0	4.0	NUM
dti-2532	2	23	)	)	PUNCT
dti-2532	2	24	.	.	PUNCT
dti-2532	3	1	commercial	commercial	ADJ
dti-2532	3	2	use	use	NOUN
dti-2532	3	3	is	be	AUX
dti-2532	3	4	not	not	PART
dti-2532	3	5	permitted	permit	VERB
dti-2532	3	6	and	and	CCONJ
dti-2532	3	7	is	be	AUX
dti-2532	3	8	subject	subject	ADJ
dti-2532	3	9	to	to	ADP
dti-2532	3	10	publisher	publisher	NOUN
dti-2532	3	11	’s	’s	PART
dti-2532	3	12	permissions	permission	NOUN
dti-2532	3	13	.	.	PUNCT
dti-2532	4	1	full	full	ADJ
dti-2532	4	2	information	information	NOUN
dti-2532	4	3	is	be	AUX
dti-2532	4	4	available	available	ADJ
dti-2532	4	5	at	at	ADP
dti-2532	4	6	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2532	4	7	focus	focus	NOUN
dti-2532	4	8	on	on	ADP
dti-2532	4	9	antimicrobial	antimicrobial	ADJ
dti-2532	4	10	resistance	resistance	NOUN
dti-2532	4	11	(	(	PUNCT
dti-2532	4	12	amr	amr	NOUN
dti-2532	4	13	)	)	PUNCT
dti-2532	4	14	unmet	unmet	NOUN
dti-2532	4	15	needs	need	NOUN
dti-2532	4	16	for	for	ADP
dti-2532	4	17	management	management	NOUN
dti-2532	4	18	of	of	ADP
dti-2532	4	19	drug	drug	NOUN
dti-2532	4	20	-	-	PUNCT
dti-2532	4	21	resistant	resistant	ADJ
dti-2532	4	22	infections	infection	NOUN
dti-2532	4	23	:	:	PUNCT
dti-2532	4	24	lowand	lowand	ADJ
dti-2532	4	25	middle	middle	ADJ
dti-2532	4	26	-	-	PUNCT
dti-2532	4	27	income	income	NOUN
dti-2532	4	28	countries	country	NOUN
dti-2532	4	29	’	'	PUNCT
dti-2532	4	30	viewpoint	viewpoint	VERB
dti-2532	4	31	monica	monica	PROPN
dti-2532	4	32	sharma1	sharma1	PROPN
dti-2532	4	33	,	,	PUNCT
dti-2532	4	34	kamini	kamini	PROPN
dti-2532	4	35	walia1	walia1	PROPN
dti-2532	4	36	,	,	PUNCT
dti-2532	4	37	nitin	nitin	PROPN
dti-2532	4	38	bansal2	bansal2	PROPN
dti-2532	5	1	1division	1division	NUM
dti-2532	5	2	of	of	ADP
dti-2532	5	3	epidemiology	epidemiology	NOUN
dti-2532	5	4	and	and	CCONJ
dti-2532	5	5	communicable	communicable	NOUN
dti-2532	5	6	diseases	disease	NOUN
dti-2532	5	7	,	,	PUNCT
dti-2532	5	8	indian	indian	PROPN
dti-2532	5	9	council	council	PROPN
dti-2532	5	10	of	of	ADP
dti-2532	5	11	medical	medical	ADJ
dti-2532	5	12	research	research	NOUN
dti-2532	5	13	,	,	PUNCT
dti-2532	5	14	new	new	PROPN
dti-2532	5	15	delhi	delhi	PROPN
dti-2532	5	16	india	india	PROPN
dti-2532	5	17	2rajiv	2rajiv	PROPN
dti-2532	5	18	gandhi	gandhi	PROPN
dti-2532	5	19	cancer	cancer	PROPN
dti-2532	5	20	institute	institute	PROPN
dti-2532	5	21	and	and	CCONJ
dti-2532	5	22	research	research	NOUN
dti-2532	5	23	centre	centre	NOUN
dti-2532	5	24	,	,	PUNCT
dti-2532	5	25	new	new	ADJ
dti-2532	5	26	delhi	delhi	PROPN
dti-2532	5	27	india	india	PROPN
dti-2532	5	28	abstract	abstract	ADJ
dti-2532	5	29	drug	drug	NOUN
dti-2532	5	30	-	-	PUNCT
dti-2532	5	31	resistant	resistant	ADJ
dti-2532	5	32	infections	infection	NOUN
dti-2532	5	33	are	be	AUX
dti-2532	5	34	a	a	DET
dti-2532	5	35	serious	serious	ADJ
dti-2532	5	36	threat	threat	NOUN
dti-2532	5	37	globally	globally	ADV
dti-2532	5	38	which	which	PRON
dti-2532	5	39	demands	demand	VERB
dti-2532	5	40	cost	cost	NOUN
dti-2532	5	41	-	-	PUNCT
dti-2532	5	42	effective	effective	ADJ
dti-2532	5	43	solutions	solution	NOUN
dti-2532	5	44	to	to	PART
dti-2532	5	45	meet	meet	VERB
dti-2532	5	46	the	the	DET
dti-2532	5	47	unmet	unmet	NOUN
dti-2532	5	48	needs	need	NOUN
dti-2532	5	49	in	in	ADP
dti-2532	5	50	their	their	PRON
dti-2532	5	51	diagnosis	diagnosis	NOUN
dti-2532	5	52	and	and	CCONJ
dti-2532	5	53	treatment	treatment	NOUN
dti-2532	5	54	.	.	PUNCT
dti-2532	6	1	gram	gram	NOUN
dti-2532	6	2	-	-	PUNCT
dti-2532	6	3	negative	negative	ADJ
dti-2532	6	4	pathogens	pathogen	NOUN
dti-2532	6	5	,	,	PUNCT
dti-2532	6	6	drug	drug	NOUN
dti-2532	6	7	-	-	PUNCT
dti-2532	6	8	resistant	resistant	ADJ
dti-2532	6	9	tuberculosis	tuberculosis	NOUN
dti-2532	6	10	,	,	PUNCT
dti-2532	6	11	and	and	CCONJ
dti-2532	6	12	multidrugresistant	multidrugresistant	ADJ
dti-2532	6	13	salmonella	salmonella	NOUN
dti-2532	6	14	typhi	typhi	ADV
dti-2532	6	15	have	have	AUX
dti-2532	6	16	been	be	AUX
dti-2532	6	17	reported	report	VERB
dti-2532	6	18	as	as	ADP
dti-2532	6	19	cause	cause	NOUN
dti-2532	6	20	of	of	ADP
dti-2532	6	21	resistant	resistant	ADJ
dti-2532	6	22	infections	infection	NOUN
dti-2532	6	23	in	in	ADP
dti-2532	6	24	developing	develop	VERB
dti-2532	6	25	countries	country	NOUN
dti-2532	6	26	.	.	PUNCT
dti-2532	7	1	here	here	ADV
dti-2532	7	2	,	,	PUNCT
dti-2532	7	3	we	we	PRON
dti-2532	7	4	discuss	discuss	VERB
dti-2532	7	5	the	the	DET
dti-2532	7	6	priority	priority	NOUN
dti-2532	7	7	pathogens	pathogen	NOUN
dti-2532	7	8	and	and	CCONJ
dti-2532	7	9	conditions	condition	NOUN
dti-2532	7	10	for	for	ADP
dti-2532	7	11	which	which	PRON
dti-2532	7	12	feasible	feasible	ADJ
dti-2532	7	13	solutions	solution	NOUN
dti-2532	7	14	adaptable	adaptable	ADJ
dti-2532	7	15	to	to	ADP
dti-2532	7	16	low	low	ADJ
dti-2532	7	17	-	-	PUNCT
dti-2532	7	18	resource	resource	NOUN
dti-2532	7	19	settings	setting	NOUN
dti-2532	7	20	are	be	AUX
dti-2532	7	21	required	require	VERB
dti-2532	7	22	to	to	PART
dti-2532	7	23	address	address	VERB
dti-2532	7	24	the	the	DET
dti-2532	7	25	antimicrobial	antimicrobial	ADJ
dti-2532	7	26	resistance	resistance	NOUN
dti-2532	7	27	in	in	ADP
dti-2532	7	28	pathogens	pathogen	NOUN
dti-2532	7	29	.	.	PUNCT
dti-2532	8	1	these	these	DET
dti-2532	8	2	solutions	solution	NOUN
dti-2532	8	3	will	will	AUX
dti-2532	8	4	be	be	AUX
dti-2532	8	5	helpful	helpful	ADJ
dti-2532	8	6	in	in	ADP
dti-2532	8	7	containing	contain	VERB
dti-2532	8	8	the	the	DET
dti-2532	8	9	spread	spread	NOUN
dti-2532	8	10	of	of	ADP
dti-2532	8	11	antimicrobial	antimicrobial	ADJ
dti-2532	8	12	resistance	resistance	NOUN
dti-2532	8	13	and	and	CCONJ
dti-2532	8	14	better	well	ADJ
dti-2532	8	15	patient	patient	ADJ
dti-2532	8	16	outcomes	outcome	NOUN
dti-2532	8	17	.	.	PUNCT
dti-2532	9	1	keywords	keyword	NOUN
dti-2532	9	2	:	:	PUNCT
dti-2532	9	3	antibiotic	antibiotic	ADJ
dti-2532	9	4	,	,	PUNCT
dti-2532	9	5	antimicrobial	antimicrobial	ADJ
dti-2532	9	6	resistance	resistance	NOUN
dti-2532	9	7	,	,	PUNCT
dti-2532	9	8	diagnostics	diagnostic	NOUN
dti-2532	9	9	,	,	PUNCT
dti-2532	9	10	india	india	PROPN
dti-2532	9	11	,	,	PUNCT
dti-2532	9	12	infection	infection	NOUN
dti-2532	9	13	,	,	PUNCT
dti-2532	9	14	lowand	lowand	ADJ
dti-2532	9	15	middle	middle	ADJ
dti-2532	9	16	-	-	PUNCT
dti-2532	9	17	income	income	NOUN
dti-2532	9	18	countries	country	NOUN
dti-2532	9	19	received	receive	VERB
dti-2532	9	20	:	:	PUNCT
dti-2532	9	21	november	november	PROPN
dti-2532	9	22	30	30	NUM
dti-2532	9	23	,	,	PUNCT
dti-2532	9	24	2022	2022	NUM
dti-2532	9	25	accepted	accept	VERB
dti-2532	9	26	:	:	PUNCT
dti-2532	9	27	december	december	PROPN
dti-2532	9	28	26	26	NUM
dti-2532	9	29	,	,	PUNCT
dti-2532	9	30	2022	2022	NUM
dti-2532	9	31	published	publish	VERB
dti-2532	9	32	online	online	ADV
dti-2532	9	33	:	:	PUNCT
dti-2532	9	34	december	december	PROPN
dti-2532	9	35	31	31	NUM
dti-2532	9	36	,	,	PUNCT
dti-2532	9	37	2022	2022	NUM
dti-2532	9	38	corresponding	correspond	VERB
dti-2532	9	39	author	author	NOUN
dti-2532	9	40	:	:	PUNCT
dti-2532	9	41	dr	dr	PROPN
dti-2532	9	42	.	.	PROPN
dti-2532	9	43	monica	monica	PROPN
dti-2532	9	44	sharma	sharma	PROPN
dti-2532	9	45	division	division	NOUN
dti-2532	9	46	of	of	ADP
dti-2532	9	47	epidemiology	epidemiology	NOUN
dti-2532	9	48	and	and	CCONJ
dti-2532	9	49	communicable	communicable	NOUN
dti-2532	9	50	diseases	disease	NOUN
dti-2532	9	51	indian	indian	PROPN
dti-2532	9	52	council	council	PROPN
dti-2532	9	53	of	of	ADP
dti-2532	9	54	medical	medical	ADJ
dti-2532	9	55	research	research	NOUN
dti-2532	9	56	ansari	ansari	ADJ
dti-2532	9	57	nagar	nagar	NOUN
dti-2532	9	58	,	,	PUNCT
dti-2532	9	59	new	new	ADJ
dti-2532	9	60	delhi	delhi	PROPN
dti-2532	9	61	,	,	PUNCT
dti-2532	9	62	pin	pin	NOUN
dti-2532	9	63	110029	110029	NUM
dti-2532	9	64	india	india	PROPN
dti-2532	9	65	sharmasankhyan@gmail.com	sharmasankhyan@gmail.com	PROPN
dti-2532	9	66	escherichia	escherichia	NOUN
dti-2532	9	67	coli	coli	NOUN
dti-2532	9	68	,	,	PUNCT
dti-2532	9	69	klebsiella	klebsiella	NOUN
dti-2532	9	70	pneumoniae	pneumoniae	NOUN
dti-2532	9	71	,	,	PUNCT
dti-2532	9	72	acinetobacter	acinetobacter	ADV
dti-2532	9	73	baumannii	baumannii	PROPN
dti-2532	9	74	,	,	PUNCT
dti-2532	9	75	pseudomonas	pseudomona	NOUN
dti-2532	9	76	aeruginosa	aeruginosa	NOUN
dti-2532	9	77	,	,	PUNCT
dti-2532	9	78	and	and	CCONJ
dti-2532	9	79	enterobacter	enterobacter	ADJ
dti-2532	9	80	spp	spp	NOUN
dti-2532	9	81	.	.	PUNCT
dti-2532	10	1	have	have	AUX
dti-2532	10	2	become	become	VERB
dti-2532	10	3	public	public	ADJ
dti-2532	10	4	health	health	NOUN
dti-2532	10	5	concerns	concern	NOUN
dti-2532	10	6	(	(	PUNCT
dti-2532	10	7	3,7,8	3,7,8	NUM
dti-2532	10	8	)	)	PUNCT
dti-2532	10	9	that	that	PRON
dti-2532	10	10	are	be	AUX
dti-2532	10	11	difficult	difficult	ADJ
dti-2532	10	12	to	to	PART
dti-2532	10	13	control	control	VERB
dti-2532	10	14	due	due	ADP
dti-2532	10	15	to	to	ADP
dti-2532	10	16	acquisition	acquisition	NOUN
dti-2532	10	17	of	of	ADP
dti-2532	10	18	different	different	ADJ
dti-2532	10	19	resistance	resistance	NOUN
dti-2532	10	20	markers	marker	NOUN
dti-2532	10	21	.	.	PUNCT
dti-2532	11	1	streptococcus	streptococcus	VERB
dti-2532	11	2	pneumoniae	pneumoniae	ADJ
dti-2532	11	3	infections	infection	NOUN
dti-2532	11	4	have	have	AUX
dti-2532	11	5	been	be	AUX
dti-2532	11	6	associated	associate	VERB
dti-2532	11	7	with	with	ADP
dti-2532	11	8	high	high	ADJ
dti-2532	11	9	mortality	mortality	NOUN
dti-2532	11	10	in	in	ADP
dti-2532	11	11	children	child	NOUN
dti-2532	11	12	aged	age	VERB
dti-2532	11	13	below	below	ADP
dti-2532	11	14	5	5	NUM
dti-2532	11	15	years	year	NOUN
dti-2532	11	16	,	,	PUNCT
dti-2532	11	17	and	and	CCONJ
dti-2532	11	18	in	in	ADP
dti-2532	11	19	2015	2015	NUM
dti-2532	11	20	,	,	PUNCT
dti-2532	11	21	50	50	NUM
dti-2532	11	22	%	%	NOUN
dti-2532	11	23	of	of	ADP
dti-2532	11	24	all	all	DET
dti-2532	11	25	pneumococcal	pneumococcal	ADJ
dti-2532	11	26	deaths	death	NOUN
dti-2532	11	27	were	be	AUX
dti-2532	11	28	reported	report	VERB
dti-2532	11	29	in	in	ADP
dti-2532	11	30	four	four	NUM
dti-2532	11	31	countries	country	NOUN
dti-2532	11	32	of	of	ADP
dti-2532	11	33	africa	africa	PROPN
dti-2532	11	34	and	and	CCONJ
dti-2532	11	35	asia	asia	PROPN
dti-2532	11	36	(	(	PUNCT
dti-2532	11	37	3,9	3,9	NUM
dti-2532	11	38	)	)	PUNCT
dti-2532	11	39	.	.	PUNCT
dti-2532	12	1	in	in	ADP
dti-2532	12	2	neonates	neonate	NOUN
dti-2532	12	3	,	,	PUNCT
dti-2532	12	4	antimicrobialresistant	antimicrobialresistant	ADJ
dti-2532	12	5	infections	infection	NOUN
dti-2532	12	6	have	have	AUX
dti-2532	12	7	been	be	AUX
dti-2532	12	8	associated	associate	VERB
dti-2532	12	9	with	with	ADP
dti-2532	12	10	approximately	approximately	ADV
dti-2532	12	11	23	23	NUM
dti-2532	12	12	%	%	NOUN
dti-2532	12	13	of	of	ADP
dti-2532	12	14	deaths	death	NOUN
dti-2532	12	15	,	,	PUNCT
dti-2532	12	16	with	with	ADP
dti-2532	12	17	over	over	ADP
dti-2532	12	18	55	55	NUM
dti-2532	12	19	%	%	NOUN
dti-2532	12	20	of	of	ADP
dti-2532	12	21	amr	amr	ADJ
dti-2532	12	22	prevalence	prevalence	NOUN
dti-2532	12	23	among	among	ADP
dti-2532	12	24	sepsis	sepsis	NOUN
dti-2532	12	25	-	-	PUNCT
dti-2532	12	26	causing	cause	VERB
dti-2532	12	27	pathogens	pathogen	NOUN
dti-2532	12	28	(	(	PUNCT
dti-2532	12	29	3,10	3,10	NUM
dti-2532	12	30	)	)	PUNCT
dti-2532	12	31	.	.	PUNCT
dti-2532	13	1	published	publish	VERB
dti-2532	13	2	data	datum	NOUN
dti-2532	13	3	from	from	ADP
dti-2532	13	4	india	india	PROPN
dti-2532	13	5	have	have	AUX
dti-2532	13	6	reported	report	VERB
dti-2532	13	7	concerning	concern	VERB
dti-2532	13	8	rates	rate	NOUN
dti-2532	13	9	of	of	ADP
dti-2532	13	10	amr	amr	NOUN
dti-2532	13	11	among	among	ADP
dti-2532	13	12	pathogens	pathogen	NOUN
dti-2532	13	13	including	include	VERB
dti-2532	13	14	enterococcus	enterococcus	NOUN
dti-2532	13	15	faecium	faecium	NOUN
dti-2532	13	16	,	,	PUNCT
dti-2532	13	17	staphylococcus	staphylococcus	NOUN
dti-2532	13	18	aureus	aureus	NOUN
dti-2532	13	19	,	,	PUNCT
dti-2532	13	20	enterobacter	enterobacter	ADJ
dti-2532	13	21	spp	spp	NOUN
dti-2532	13	22	.	.	PROPN
dti-2532	13	23	,	,	PUNCT
dti-2532	13	24	salmonella	salmonella	NOUN
dti-2532	13	25	typhi	typhi	ADV
dti-2532	13	26	,	,	PUNCT
dti-2532	13	27	etc	etc	X
dti-2532	13	28	.	.	X
dti-2532	14	1	(	(	PUNCT
dti-2532	14	2	7,11,12	7,11,12	NUM
dti-2532	14	3	)	)	PUNCT
dti-2532	14	4	.	.	PUNCT
dti-2532	15	1	an	an	DET
dti-2532	15	2	increase	increase	NOUN
dti-2532	15	3	in	in	ADP
dti-2532	15	4	infections	infection	NOUN
dti-2532	15	5	due	due	ADP
dti-2532	15	6	to	to	ADP
dti-2532	15	7	carbapenemresistant	carbapenemresistant	PROPN
dti-2532	15	8	k.	k.	PROPN
dti-2532	16	1	pneumoniae	pneumoniae	PROPN
dti-2532	16	2	and	and	CCONJ
dti-2532	16	3	a.	a.	NOUN
dti-2532	16	4	baumannii	baumannii	PROPN
dti-2532	16	5	has	have	AUX
dti-2532	16	6	been	be	AUX
dti-2532	16	7	reported	report	VERB
dti-2532	16	8	from	from	ADP
dti-2532	16	9	india	india	PROPN
dti-2532	16	10	and	and	CCONJ
dti-2532	16	11	other	other	ADJ
dti-2532	16	12	countries	country	NOUN
dti-2532	16	13	(	(	PUNCT
dti-2532	16	14	7,11,13	7,11,13	NUM
dti-2532	16	15	)	)	PUNCT
dti-2532	16	16	.	.	PUNCT
dti-2532	17	1	hospital	hospital	NOUN
dti-2532	17	2	-	-	PUNCT
dti-2532	17	3	acquired	acquire	VERB
dti-2532	17	4	infections	infection	NOUN
dti-2532	17	5	(	(	PUNCT
dti-2532	17	6	hais	hais	PROPN
dti-2532	17	7	)	)	PUNCT
dti-2532	17	8	are	be	AUX
dti-2532	17	9	another	another	DET
dti-2532	17	10	major	major	ADJ
dti-2532	17	11	concern	concern	NOUN
dti-2532	17	12	especially	especially	ADV
dti-2532	17	13	in	in	ADP
dti-2532	17	14	resource	resource	NOUN
dti-2532	17	15	-	-	PUNCT
dti-2532	17	16	constrained	constrain	VERB
dti-2532	17	17	low	low	ADJ
dti-2532	17	18	-	-	PUNCT
dti-2532	17	19	income	income	NOUN
dti-2532	17	20	settings	setting	NOUN
dti-2532	17	21	where	where	SCONJ
dti-2532	17	22	higher	high	ADJ
dti-2532	17	23	infection	infection	NOUN
dti-2532	17	24	rates	rate	NOUN
dti-2532	17	25	due	due	ADJ
dti-2532	17	26	to	to	ADP
dti-2532	17	27	gram	gram	NOUN
dti-2532	17	28	-	-	PUNCT
dti-2532	17	29	negative	negative	ADJ
dti-2532	17	30	pathogens	pathogen	NOUN
dti-2532	17	31	have	have	AUX
dti-2532	17	32	been	be	AUX
dti-2532	17	33	reported	report	VERB
dti-2532	17	34	than	than	ADP
dti-2532	17	35	in	in	ADP
dti-2532	17	36	developed	developed	ADJ
dti-2532	17	37	countries	country	NOUN
dti-2532	17	38	(	(	PUNCT
dti-2532	17	39	11,14	11,14	NUM
dti-2532	17	40	)	)	PUNCT
dti-2532	17	41	.	.	PUNCT
dti-2532	18	1	a	a	DET
dti-2532	18	2	recent	recent	ADJ
dti-2532	18	3	hai	hai	PROPN
dti-2532	18	4	surveillance	surveillance	NOUN
dti-2532	18	5	study	study	NOUN
dti-2532	18	6	from	from	ADP
dti-2532	18	7	india	india	PROPN
dti-2532	18	8	reported	report	VERB
dti-2532	18	9	high	high	ADJ
dti-2532	18	10	rates	rate	NOUN
dti-2532	18	11	of	of	ADP
dti-2532	18	12	carbapenem	carbapenem	PROPN
dti-2532	18	13	resistance	resistance	NOUN
dti-2532	18	14	in	in	ADP
dti-2532	18	15	klebsiella	klebsiella	PROPN
dti-2532	18	16	spp	spp	PROPN
dti-2532	18	17	.	.	PROPN
dti-2532	18	18	,	,	PUNCT
dti-2532	18	19	acinetobacter	acinetobacter	PROPN
dti-2532	18	20	spp	spp	NOUN
dti-2532	18	21	.	.	PUNCT
dti-2532	18	22	,	,	PUNCT
dti-2532	18	23	and	and	CCONJ
dti-2532	18	24	pseudomonas	pseudomona	VERB
dti-2532	18	25	spp	spp	NOUN
dti-2532	18	26	.	.	PUNCT
dti-2532	19	1	(	(	PUNCT
dti-2532	19	2	15	15	NUM
dti-2532	19	3	)	)	PUNCT
dti-2532	19	4	and	and	CCONJ
dti-2532	19	5	observed	observe	VERB
dti-2532	19	6	reduced	reduce	VERB
dti-2532	19	7	susceptibility	susceptibility	NOUN
dti-2532	19	8	to	to	ADP
dti-2532	19	9	extended	extend	VERB
dti-2532	19	10	-	-	PUNCT
dti-2532	19	11	spectrum	spectrum	NOUN
dti-2532	19	12	cephalosporins	cephalosporin	NOUN
dti-2532	19	13	.	.	PUNCT
dti-2532	20	1	this	this	DET
dti-2532	20	2	study	study	NOUN
dti-2532	20	3	also	also	ADV
dti-2532	20	4	highlights	highlight	VERB
dti-2532	20	5	candida	candida	PROPN
dti-2532	20	6	auris	auris	PROPN
dti-2532	20	7	as	as	ADP
dti-2532	20	8	an	an	DET
dti-2532	20	9	emerging	emerge	VERB
dti-2532	20	10	multidrug	multidrug	NOUN
dti-2532	20	11	-	-	PUNCT
dti-2532	20	12	resistant	resistant	ADJ
dti-2532	20	13	threat	threat	NOUN
dti-2532	20	14	in	in	ADP
dti-2532	20	15	bloodstream	bloodstream	NOUN
dti-2532	20	16	infection	infection	NOUN
dti-2532	20	17	(	(	PUNCT
dti-2532	20	18	bsi	bsi	PROPN
dti-2532	20	19	)	)	PUNCT
dti-2532	20	20	and	and	CCONJ
dti-2532	20	21	urinary	urinary	ADJ
dti-2532	20	22	tract	tract	NOUN
dti-2532	20	23	infection	infection	NOUN
dti-2532	20	24	(	(	PUNCT
dti-2532	20	25	uti	uti	PROPN
dti-2532	20	26	)	)	PUNCT
dti-2532	20	27	.	.	PUNCT
dti-2532	21	1	therefore	therefore	ADV
dti-2532	21	2	,	,	PUNCT
dti-2532	21	3	fungal	fungal	ADJ
dti-2532	21	4	pathogens	pathogen	NOUN
dti-2532	21	5	such	such	ADJ
dti-2532	21	6	as	as	ADP
dti-2532	21	7	candida	candida	PROPN
dti-2532	21	8	spp	spp	PROPN
dti-2532	21	9	.	.	PUNCT
dti-2532	21	10	require	require	VERB
dti-2532	21	11	close	close	ADJ
dti-2532	21	12	monitoring	monitoring	NOUN
dti-2532	21	13	for	for	ADP
dti-2532	21	14	trends	trend	NOUN
dti-2532	21	15	of	of	ADP
dti-2532	21	16	infections	infection	NOUN
dti-2532	21	17	,	,	PUNCT
dti-2532	21	18	outbreaks	outbreak	NOUN
dti-2532	21	19	,	,	PUNCT
dti-2532	21	20	and	and	CCONJ
dti-2532	21	21	susceptibility	susceptibility	NOUN
dti-2532	21	22	.	.	PUNCT
dti-2532	22	1	introduction	introduction	NOUN
dti-2532	22	2	drug	drug	NOUN
dti-2532	22	3	-	-	PUNCT
dti-2532	22	4	resistant	resistant	ADJ
dti-2532	22	5	infections	infection	NOUN
dti-2532	22	6	are	be	AUX
dti-2532	22	7	major	major	ADJ
dti-2532	22	8	public	public	ADJ
dti-2532	22	9	health	health	NOUN
dti-2532	22	10	concerns	concern	NOUN
dti-2532	22	11	that	that	PRON
dti-2532	22	12	are	be	AUX
dti-2532	22	13	associated	associate	VERB
dti-2532	22	14	with	with	ADP
dti-2532	22	15	high	high	ADJ
dti-2532	22	16	morbidity	morbidity	NOUN
dti-2532	22	17	and	and	CCONJ
dti-2532	22	18	mortality	mortality	NOUN
dti-2532	22	19	in	in	ADP
dti-2532	22	20	patients	patient	NOUN
dti-2532	22	21	,	,	PUNCT
dti-2532	22	22	and	and	CCONJ
dti-2532	22	23	result	result	VERB
dti-2532	22	24	in	in	ADP
dti-2532	22	25	exorbitant	exorbitant	ADJ
dti-2532	22	26	health	health	NOUN
dti-2532	22	27	and	and	CCONJ
dti-2532	22	28	economic	economic	ADJ
dti-2532	22	29	burden	burden	NOUN
dti-2532	22	30	(	(	PUNCT
dti-2532	22	31	1,2	1,2	NUM
dti-2532	22	32	)	)	PUNCT
dti-2532	22	33	.	.	PUNCT
dti-2532	23	1	in	in	ADP
dti-2532	23	2	2019	2019	NUM
dti-2532	23	3	,	,	PUNCT
dti-2532	23	4	4.95	4.95	NUM
dti-2532	23	5	million	million	NUM
dti-2532	23	6	deaths	death	NOUN
dti-2532	23	7	were	be	AUX
dti-2532	23	8	estimated	estimate	VERB
dti-2532	23	9	due	due	ADJ
dti-2532	23	10	to	to	ADP
dti-2532	23	11	resistant	resistant	VERB
dti-2532	23	12	bacterial	bacterial	ADJ
dti-2532	23	13	infections	infection	NOUN
dti-2532	23	14	(	(	PUNCT
dti-2532	23	15	3	3	NUM
dti-2532	23	16	)	)	PUNCT
dti-2532	23	17	.	.	PUNCT
dti-2532	24	1	the	the	DET
dti-2532	24	2	burden	burden	NOUN
dti-2532	24	3	of	of	ADP
dti-2532	24	4	drug	drug	NOUN
dti-2532	24	5	resistant	resistant	ADJ
dti-2532	24	6	infections	infection	NOUN
dti-2532	24	7	remains	remain	VERB
dti-2532	24	8	high	high	ADJ
dti-2532	24	9	in	in	ADP
dti-2532	24	10	low	low	ADJ
dti-2532	24	11	-	-	PUNCT
dti-2532	24	12	resource	resource	NOUN
dti-2532	24	13	healthcare	healthcare	NOUN
dti-2532	24	14	settings	setting	NOUN
dti-2532	24	15	,	,	PUNCT
dti-2532	24	16	especially	especially	ADV
dti-2532	24	17	in	in	ADP
dti-2532	24	18	lowand	lowand	ADJ
dti-2532	24	19	middle	middle	ADJ
dti-2532	24	20	-	-	PUNCT
dti-2532	24	21	income	income	NOUN
dti-2532	24	22	countries	country	NOUN
dti-2532	24	23	(	(	PUNCT
dti-2532	24	24	lmics	lmic	NOUN
dti-2532	24	25	)	)	PUNCT
dti-2532	24	26	including	include	VERB
dti-2532	24	27	india	india	PROPN
dti-2532	24	28	(	(	PUNCT
dti-2532	24	29	3,4,1,5	3,4,1,5	NUM
dti-2532	24	30	)	)	PUNCT
dti-2532	24	31	.	.	PUNCT
dti-2532	25	1	rampant	rampant	ADJ
dti-2532	25	2	misuse	misuse	NOUN
dti-2532	25	3	of	of	ADP
dti-2532	25	4	antimicrobials	antimicrobial	NOUN
dti-2532	25	5	(	(	PUNCT
dti-2532	25	6	in	in	ADP
dti-2532	25	7	humans	human	NOUN
dti-2532	25	8	and	and	CCONJ
dti-2532	25	9	animal	animal	NOUN
dti-2532	25	10	husbandry	husbandry	NOUN
dti-2532	25	11	)	)	PUNCT
dti-2532	25	12	,	,	PUNCT
dti-2532	25	13	unregulated	unregulate	VERB
dti-2532	25	14	overthe	overthe	ADJ
dti-2532	25	15	-	-	PUNCT
dti-2532	25	16	counter	counter	NOUN
dti-2532	25	17	availability	availability	NOUN
dti-2532	25	18	,	,	PUNCT
dti-2532	25	19	poor	poor	ADJ
dti-2532	25	20	healthcare	healthcare	NOUN
dti-2532	25	21	facilities	facility	NOUN
dti-2532	25	22	and	and	CCONJ
dti-2532	25	23	infection	infection	NOUN
dti-2532	25	24	control	control	NOUN
dti-2532	25	25	practices	practice	NOUN
dti-2532	25	26	,	,	PUNCT
dti-2532	25	27	and	and	CCONJ
dti-2532	25	28	lack	lack	NOUN
dti-2532	25	29	of	of	ADP
dti-2532	25	30	accurate	accurate	ADJ
dti-2532	25	31	diagnostics	diagnostic	NOUN
dti-2532	25	32	to	to	PART
dti-2532	25	33	support	support	VERB
dti-2532	25	34	treatment	treatment	NOUN
dti-2532	25	35	decisions	decision	NOUN
dti-2532	25	36	are	be	AUX
dti-2532	25	37	few	few	ADJ
dti-2532	25	38	of	of	ADP
dti-2532	25	39	the	the	DET
dti-2532	25	40	major	major	ADJ
dti-2532	25	41	drivers	driver	NOUN
dti-2532	25	42	of	of	ADP
dti-2532	25	43	antimicrobial	antimicrobial	ADJ
dti-2532	25	44	resistance	resistance	NOUN
dti-2532	25	45	(	(	PUNCT
dti-2532	25	46	amr	amr	NOUN
dti-2532	25	47	)	)	PUNCT
dti-2532	25	48	in	in	ADP
dti-2532	25	49	communities	community	NOUN
dti-2532	25	50	and	and	CCONJ
dti-2532	25	51	hospitals	hospital	NOUN
dti-2532	25	52	(	(	PUNCT
dti-2532	25	53	5,6	5,6	NUM
dti-2532	25	54	)	)	PUNCT
dti-2532	25	55	.	.	PUNCT
dti-2532	26	1	in	in	ADP
dti-2532	26	2	the	the	DET
dti-2532	26	3	past	past	ADJ
dti-2532	26	4	few	few	ADJ
dti-2532	26	5	years	year	NOUN
dti-2532	26	6	,	,	PUNCT
dti-2532	26	7	reports	report	NOUN
dti-2532	26	8	on	on	ADP
dti-2532	26	9	multidrug	multidrug	NOUN
dti-2532	26	10	-	-	PUNCT
dti-2532	26	11	resistant	resistant	ADJ
dti-2532	26	12	infections	infection	NOUN
dti-2532	26	13	due	due	ADP
dti-2532	26	14	to	to	ADP
dti-2532	26	15	gram	gram	NOUN
dti-2532	26	16	-	-	PUNCT
dti-2532	26	17	negative	negative	ADJ
dti-2532	26	18	bacteria	bacteria	NOUN
dti-2532	26	19	have	have	AUX
dti-2532	26	20	increased	increase	VERB
dti-2532	26	21	globally	globally	ADV
dti-2532	26	22	(	(	PUNCT
dti-2532	26	23	3,4	3,4	NUM
dti-2532	26	24	)	)	PUNCT
dti-2532	26	25	,	,	PUNCT
dti-2532	26	26	which	which	PRON
dti-2532	26	27	represent	represent	VERB
dti-2532	26	28	a	a	DET
dti-2532	26	29	critical	critical	ADJ
dti-2532	26	30	unmet	unmet	NOUN
dti-2532	26	31	medical	medical	ADJ
dti-2532	26	32	need	need	NOUN
dti-2532	26	33	,	,	PUNCT
dti-2532	26	34	for	for	ADP
dti-2532	26	35	which	which	PRON
dti-2532	26	36	interventions	intervention	NOUN
dti-2532	26	37	are	be	AUX
dti-2532	26	38	required	require	VERB
dti-2532	26	39	.	.	PUNCT
dti-2532	27	1	gram	gram	NOUN
dti-2532	27	2	-	-	PUNCT
dti-2532	27	3	negative	negative	ADJ
dti-2532	27	4	pathogens	pathogen	NOUN
dti-2532	27	5	https://doi.org/10.33393/dti.2022.2532	https://doi.org/10.33393/dti.2022.2532	NOUN
dti-2532	27	6	https://creativecommons.org/licenses/by-nc/4.0/legalcode	https://creativecommons.org/licenses/by-nc/4.0/legalcode	NUM
dti-2532	27	7	mailto:sharmasankhyan@gmail.com	mailto:sharmasankhyan@gmail.com	NOUN
dti-2532	27	8	sharma	sharma	PROPN
dti-2532	27	9	et	et	PROPN
dti-2532	27	10	al	al	PROPN
dti-2532	27	11	drug	drug	PROPN
dti-2532	27	12	target	target	NOUN
dti-2532	27	13	insights	insight	NOUN
dti-2532	27	14	2022	2022	NUM
dti-2532	27	15	;	;	PUNCT
dti-2532	27	16	16	16	NUM
dti-2532	27	17	:	:	SYM
dti-2532	27	18	79	79	NUM
dti-2532	27	19	©	©	ADP
dti-2532	27	20	2022	2022	NUM
dti-2532	27	21	the	the	DET
dti-2532	27	22	authors	author	NOUN
dti-2532	27	23	.	.	PUNCT
dti-2532	28	1	published	publish	VERB
dti-2532	28	2	by	by	ADP
dti-2532	28	3	aboutscience	aboutscience	NOUN
dti-2532	28	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2532	28	5	enteric	enteric	ADJ
dti-2532	28	6	fever	fever	NOUN
dti-2532	28	7	and	and	CCONJ
dti-2532	28	8	especially	especially	ADV
dti-2532	28	9	typhoidal	typhoidal	VERB
dti-2532	28	10	salmonella	salmonella	NOUN
dti-2532	28	11	endemic	endemic	ADJ
dti-2532	28	12	to	to	ADP
dti-2532	28	13	south	south	NOUN
dti-2532	28	14	and	and	CCONJ
dti-2532	28	15	southeast	southeast	PROPN
dti-2532	28	16	asia	asia	PROPN
dti-2532	28	17	and	and	CCONJ
dti-2532	28	18	sub	sub	ADJ
dti-2532	28	19	-	-	ADJ
dti-2532	28	20	saharan	saharan	ADJ
dti-2532	28	21	africa	africa	PROPN
dti-2532	28	22	require	require	VERB
dti-2532	28	23	continuous	continuous	ADJ
dti-2532	28	24	monitoring	monitoring	NOUN
dti-2532	28	25	where	where	SCONJ
dti-2532	28	26	changing	change	VERB
dti-2532	28	27	resistance	resistance	NOUN
dti-2532	28	28	trends	trend	NOUN
dti-2532	28	29	have	have	AUX
dti-2532	28	30	been	be	AUX
dti-2532	28	31	reported	report	VERB
dti-2532	28	32	due	due	ADJ
dti-2532	28	33	to	to	ADP
dti-2532	28	34	fluoroquinolones	fluoroquinolone	NOUN
dti-2532	28	35	and	and	CCONJ
dti-2532	28	36	cephalosporins	cephalosporin	NOUN
dti-2532	28	37	(	(	PUNCT
dti-2532	28	38	16	16	NUM
dti-2532	28	39	,	,	PUNCT
dti-2532	28	40	17	17	NUM
dti-2532	28	41	)	)	PUNCT
dti-2532	28	42	.	.	PUNCT
dti-2532	29	1	drug	drug	NOUN
dti-2532	29	2	-	-	PUNCT
dti-2532	29	3	resistant	resistant	ADJ
dti-2532	29	4	bacteria	bacteria	NOUN
dti-2532	29	5	such	such	ADJ
dti-2532	29	6	as	as	ADP
dti-2532	29	7	third	third	ADJ
dti-2532	29	8	-	-	PUNCT
dti-2532	29	9	generation	generation	NOUN
dti-2532	29	10	cephalosporin	cephalosporin	NOUN
dti-2532	29	11	-	-	PUNCT
dti-2532	29	12	resistant	resistant	ADJ
dti-2532	29	13	e.	e.	PROPN
dti-2532	29	14	coli	coli	PROPN
dti-2532	29	15	,	,	PUNCT
dti-2532	29	16	carbapenem	carbapenem	NOUN
dti-2532	29	17	-	-	PUNCT
dti-2532	29	18	resistant	resistant	ADJ
dti-2532	29	19	a.	a.	NOUN
dti-2532	29	20	baumannii	baumannii	PROPN
dti-2532	29	21	,	,	PUNCT
dti-2532	29	22	fluoroquinolone	fluoroquinolone	NOUN
dti-2532	29	23	-	-	PUNCT
dti-2532	29	24	resistant	resistant	ADJ
dti-2532	29	25	e.	e.	PROPN
dti-2532	29	26	coli	coli	PROPN
dti-2532	29	27	,	,	PUNCT
dti-2532	29	28	carbapenemresistant	carbapenemresistant	PROPN
dti-2532	29	29	k.	k.	PROPN
dti-2532	29	30	pneumoniae	pneumoniae	PROPN
dti-2532	29	31	,	,	PUNCT
dti-2532	29	32	and	and	CCONJ
dti-2532	29	33	third	third	ADJ
dti-2532	29	34	-	-	PUNCT
dti-2532	29	35	generation	generation	NOUN
dti-2532	29	36	cephalosporin	cephalosporin	NOUN
dti-2532	29	37	resistant	resistant	ADJ
dti-2532	29	38	k.	k.	PROPN
dti-2532	29	39	pneumoniae	pneumoniae	NOUN
dti-2532	29	40	represent	represent	VERB
dti-2532	29	41	serious	serious	ADJ
dti-2532	29	42	challenges	challenge	NOUN
dti-2532	29	43	in	in	ADP
dti-2532	29	44	patient	patient	ADJ
dti-2532	29	45	management	management	NOUN
dti-2532	29	46	,	,	PUNCT
dti-2532	29	47	especially	especially	ADV
dti-2532	29	48	in	in	ADP
dti-2532	29	49	critically	critically	ADV
dti-2532	29	50	ill	ill	ADJ
dti-2532	29	51	patient	patient	NOUN
dti-2532	29	52	with	with	ADP
dti-2532	29	53	comorbidities	comorbiditie	NOUN
dti-2532	29	54	(	(	PUNCT
dti-2532	29	55	3,4,7,11,14	3,4,7,11,14	NUM
dti-2532	29	56	)	)	PUNCT
dti-2532	29	57	.	.	PUNCT
dti-2532	30	1	treating	treat	VERB
dti-2532	30	2	these	these	DET
dti-2532	30	3	drug	drug	NOUN
dti-2532	30	4	-	-	PUNCT
dti-2532	30	5	resistant	resistant	ADJ
dti-2532	30	6	infections	infection	NOUN
dti-2532	30	7	exerts	exert	VERB
dti-2532	30	8	high	high	ADJ
dti-2532	30	9	economic	economic	ADJ
dti-2532	30	10	burden	burden	NOUN
dti-2532	30	11	on	on	ADP
dti-2532	30	12	healthcare	healthcare	NOUN
dti-2532	30	13	and	and	CCONJ
dti-2532	30	14	patients	patient	NOUN
dti-2532	30	15	.	.	PUNCT
dti-2532	31	1	therefore	therefore	ADV
dti-2532	31	2	,	,	PUNCT
dti-2532	31	3	pathogens	pathogen	NOUN
dti-2532	31	4	exhibiting	exhibit	VERB
dti-2532	31	5	resistance	resistance	NOUN
dti-2532	31	6	to	to	ADP
dti-2532	31	7	antimicrobials	antimicrobial	NOUN
dti-2532	31	8	for	for	ADP
dti-2532	31	9	which	which	PRON
dti-2532	31	10	there	there	PRON
dti-2532	31	11	are	be	VERB
dti-2532	31	12	limited	limited	ADJ
dti-2532	31	13	treatment	treatment	NOUN
dti-2532	31	14	options	option	NOUN
dti-2532	31	15	represent	represent	VERB
dti-2532	31	16	a	a	DET
dti-2532	31	17	critical	critical	ADJ
dti-2532	31	18	unmet	unmet	NOUN
dti-2532	31	19	medical	medical	ADJ
dti-2532	31	20	need	need	NOUN
dti-2532	31	21	for	for	ADP
dti-2532	31	22	diagnostics	diagnostic	NOUN
dti-2532	31	23	and	and	CCONJ
dti-2532	31	24	therapeutic	therapeutic	ADJ
dti-2532	31	25	interventions	intervention	NOUN
dti-2532	31	26	.	.	PUNCT
dti-2532	32	1	however	however	ADV
dti-2532	32	2	,	,	PUNCT
dti-2532	32	3	the	the	DET
dti-2532	32	4	priority	priority	NOUN
dti-2532	32	5	pathogens	pathogen	NOUN
dti-2532	32	6	or	or	CCONJ
dti-2532	32	7	conditions	condition	NOUN
dti-2532	32	8	as	as	ADV
dti-2532	32	9	well	well	ADV
dti-2532	32	10	as	as	ADP
dti-2532	32	11	healthcare	healthcare	NOUN
dti-2532	32	12	settings	setting	NOUN
dti-2532	32	13	need	need	VERB
dti-2532	32	14	to	to	PART
dti-2532	32	15	be	be	AUX
dti-2532	32	16	prioritized	prioritize	VERB
dti-2532	32	17	as	as	ADP
dti-2532	32	18	per	per	ADP
dti-2532	32	19	local	local	ADJ
dti-2532	32	20	healthcare	healthcare	NOUN
dti-2532	32	21	systems	system	NOUN
dti-2532	32	22	and	and	CCONJ
dti-2532	32	23	burden	burden	NOUN
dti-2532	32	24	of	of	ADP
dti-2532	32	25	resistant	resistant	ADJ
dti-2532	32	26	infections	infection	NOUN
dti-2532	32	27	.	.	PUNCT
dti-2532	33	1	managing	manage	VERB
dti-2532	33	2	and	and	CCONJ
dti-2532	33	3	containing	contain	VERB
dti-2532	33	4	drug	drug	NOUN
dti-2532	33	5	-	-	PUNCT
dti-2532	33	6	resistant	resistant	ADJ
dti-2532	33	7	infections	infection	NOUN
dti-2532	33	8	in	in	ADP
dti-2532	33	9	low	low	ADJ
dti-2532	33	10	-	-	PUNCT
dti-2532	33	11	resource	resource	NOUN
dti-2532	33	12	healthcare	healthcare	NOUN
dti-2532	33	13	settings	setting	NOUN
dti-2532	33	14	requires	require	VERB
dti-2532	33	15	a	a	DET
dti-2532	33	16	multipronged	multipronged	ADJ
dti-2532	33	17	approach	approach	NOUN
dti-2532	33	18	consisting	consist	VERB
dti-2532	33	19	of	of	ADP
dti-2532	33	20	the	the	DET
dti-2532	33	21	following	follow	VERB
dti-2532	33	22	steps	step	NOUN
dti-2532	33	23	:	:	PUNCT
dti-2532	33	24	•	•	NOUN
dti-2532	33	25	effective	effective	ADJ
dti-2532	33	26	surveillance	surveillance	NOUN
dti-2532	33	27	systems	system	NOUN
dti-2532	33	28	are	be	AUX
dti-2532	33	29	required	require	VERB
dti-2532	33	30	to	to	PART
dti-2532	33	31	provide	provide	VERB
dti-2532	33	32	correct	correct	ADJ
dti-2532	33	33	estimates	estimate	NOUN
dti-2532	33	34	of	of	ADP
dti-2532	33	35	drug	drug	NOUN
dti-2532	33	36	-	-	PUNCT
dti-2532	33	37	resistant	resistant	ADJ
dti-2532	33	38	infections	infection	NOUN
dti-2532	33	39	at	at	ADP
dti-2532	33	40	national	national	ADJ
dti-2532	33	41	and	and	CCONJ
dti-2532	33	42	regional	regional	ADJ
dti-2532	33	43	levels	level	NOUN
dti-2532	33	44	.	.	PUNCT
dti-2532	34	1	•	•	NOUN
dti-2532	34	2	strengthening	strengthening	NOUN
dti-2532	34	3	of	of	ADP
dti-2532	34	4	existing	exist	VERB
dti-2532	34	5	healthcare	healthcare	NOUN
dti-2532	34	6	facilities	facility	NOUN
dti-2532	34	7	by	by	ADP
dti-2532	34	8	improving	improve	VERB
dti-2532	34	9	availability	availability	NOUN
dti-2532	34	10	of	of	ADP
dti-2532	34	11	laboratory	laboratory	NOUN
dti-2532	34	12	services	service	NOUN
dti-2532	34	13	,	,	PUNCT
dti-2532	34	14	diagnostics	diagnostic	NOUN
dti-2532	34	15	,	,	PUNCT
dti-2532	34	16	and	and	CCONJ
dti-2532	34	17	trained	train	VERB
dti-2532	34	18	health	health	NOUN
dti-2532	34	19	personnel	personnel	NOUN
dti-2532	34	20	and	and	CCONJ
dti-2532	34	21	,	,	PUNCT
dti-2532	34	22	in	in	ADP
dti-2532	34	23	parallel	parallel	NOUN
dti-2532	34	24	,	,	PUNCT
dti-2532	34	25	enabling	enable	VERB
dti-2532	34	26	new	new	ADJ
dti-2532	34	27	health	health	NOUN
dti-2532	34	28	facilities	facility	NOUN
dti-2532	34	29	at	at	ADP
dti-2532	34	30	peripheral	peripheral	ADJ
dti-2532	34	31	settings	setting	NOUN
dti-2532	34	32	.	.	PUNCT
dti-2532	35	1	•	•	NUM
dti-2532	35	2	supporting	support	VERB
dti-2532	35	3	research	research	NOUN
dti-2532	35	4	and	and	CCONJ
dti-2532	35	5	innovations	innovation	NOUN
dti-2532	35	6	to	to	PART
dti-2532	35	7	develop	develop	VERB
dti-2532	35	8	rapid	rapid	ADJ
dti-2532	35	9	diagnostics	diagnostic	NOUN
dti-2532	35	10	and	and	CCONJ
dti-2532	35	11	new	new	ADJ
dti-2532	35	12	treatment	treatment	NOUN
dti-2532	35	13	options	option	NOUN
dti-2532	35	14	such	such	ADJ
dti-2532	35	15	as	as	ADP
dti-2532	35	16	drug	drug	NOUN
dti-2532	35	17	molecules	molecule	NOUN
dti-2532	35	18	,	,	PUNCT
dti-2532	35	19	targeted	target	VERB
dti-2532	35	20	therapies	therapy	NOUN
dti-2532	35	21	,	,	PUNCT
dti-2532	35	22	vaccines	vaccine	NOUN
dti-2532	35	23	,	,	PUNCT
dti-2532	35	24	and	and	CCONJ
dti-2532	35	25	repurposing	repurpose	VERB
dti-2532	35	26	old	old	ADJ
dti-2532	35	27	antibiotics	antibiotic	NOUN
dti-2532	35	28	.	.	PUNCT
dti-2532	36	1	•	•	NUM
dti-2532	36	2	effective	effective	ADJ
dti-2532	36	3	socio	socio	NOUN
dti-2532	36	4	-	-	PUNCT
dti-2532	36	5	behavioral	behavioral	ADJ
dti-2532	36	6	tools	tool	NOUN
dti-2532	36	7	and	and	CCONJ
dti-2532	36	8	systems	system	NOUN
dti-2532	36	9	to	to	PART
dti-2532	36	10	create	create	VERB
dti-2532	36	11	awareness	awareness	NOUN
dti-2532	36	12	among	among	ADP
dti-2532	36	13	prescribers	prescriber	NOUN
dti-2532	36	14	and	and	CCONJ
dti-2532	36	15	general	general	ADJ
dti-2532	36	16	public	public	NOUN
dti-2532	36	17	to	to	PART
dti-2532	36	18	enable	enable	VERB
dti-2532	36	19	judicious	judicious	ADJ
dti-2532	36	20	utilization	utilization	NOUN
dti-2532	36	21	of	of	ADP
dti-2532	36	22	existing	exist	VERB
dti-2532	36	23	antimicrobials	antimicrobial	NOUN
dti-2532	36	24	.	.	PUNCT
dti-2532	37	1	addressing	address	VERB
dti-2532	37	2	the	the	DET
dti-2532	37	3	diagnostic	diagnostic	ADJ
dti-2532	37	4	gap	gap	NOUN
dti-2532	37	5	improving	improve	VERB
dti-2532	37	6	diagnosis	diagnosis	NOUN
dti-2532	37	7	helps	help	VERB
dti-2532	37	8	in	in	ADP
dti-2532	37	9	generating	generate	VERB
dti-2532	37	10	evidence	evidence	NOUN
dti-2532	37	11	-	-	PUNCT
dti-2532	37	12	based	base	VERB
dti-2532	37	13	prescriptions	prescription	NOUN
dti-2532	37	14	to	to	PART
dti-2532	37	15	reduce	reduce	VERB
dti-2532	37	16	empirical	empirical	ADJ
dti-2532	37	17	use	use	NOUN
dti-2532	37	18	of	of	ADP
dti-2532	37	19	antimicrobials	antimicrobial	NOUN
dti-2532	37	20	.	.	PUNCT
dti-2532	38	1	there	there	PRON
dti-2532	38	2	is	be	VERB
dti-2532	38	3	a	a	DET
dti-2532	38	4	need	need	NOUN
dti-2532	38	5	for	for	ADP
dti-2532	38	6	quality	quality	NOUN
dti-2532	38	7	diagnostics	diagnostic	NOUN
dti-2532	38	8	with	with	ADP
dti-2532	38	9	fast	fast	ADJ
dti-2532	38	10	turnaround	turnaround	NOUN
dti-2532	38	11	time	time	NOUN
dti-2532	38	12	for	for	ADP
dti-2532	38	13	pathogen	pathogen	NOUN
dti-2532	38	14	identification	identification	NOUN
dti-2532	38	15	and	and	CCONJ
dti-2532	38	16	susceptibility	susceptibility	NOUN
dti-2532	38	17	testing	testing	NOUN
dti-2532	38	18	to	to	PART
dti-2532	38	19	address	address	VERB
dti-2532	38	20	the	the	DET
dti-2532	38	21	problem	problem	NOUN
dti-2532	38	22	of	of	ADP
dti-2532	38	23	amr	amr	PROPN
dti-2532	38	24	(	(	PUNCT
dti-2532	38	25	18	18	NUM
dti-2532	38	26	)	)	PUNCT
dti-2532	38	27	.	.	PUNCT
dti-2532	39	1	in	in	ADP
dti-2532	39	2	lmics	lmic	NOUN
dti-2532	39	3	,	,	PUNCT
dti-2532	39	4	accurate	accurate	ADJ
dti-2532	39	5	and	and	CCONJ
dti-2532	39	6	affordable	affordable	ADJ
dti-2532	39	7	diagnostic	diagnostic	ADJ
dti-2532	39	8	tests	test	NOUN
dti-2532	39	9	to	to	PART
dti-2532	39	10	differentiate	differentiate	VERB
dti-2532	39	11	viral	viral	ADJ
dti-2532	39	12	and	and	CCONJ
dti-2532	39	13	bacterial	bacterial	ADJ
dti-2532	39	14	infections	infection	NOUN
dti-2532	39	15	are	be	AUX
dti-2532	39	16	a	a	DET
dti-2532	39	17	priority	priority	NOUN
dti-2532	39	18	where	where	SCONJ
dti-2532	39	19	resources	resource	NOUN
dti-2532	39	20	and	and	CCONJ
dti-2532	39	21	capacities	capacity	NOUN
dti-2532	39	22	are	be	AUX
dti-2532	39	23	limited	limit	VERB
dti-2532	39	24	,	,	PUNCT
dti-2532	39	25	and	and	CCONJ
dti-2532	39	26	antibiotics	antibiotic	NOUN
dti-2532	39	27	are	be	AUX
dti-2532	39	28	routinely	routinely	ADV
dti-2532	39	29	misused	misuse	VERB
dti-2532	39	30	for	for	ADP
dti-2532	39	31	viral	viral	ADJ
dti-2532	39	32	infections	infection	NOUN
dti-2532	39	33	.	.	PUNCT
dti-2532	40	1	diagnostics	diagnostic	NOUN
dti-2532	40	2	for	for	ADP
dti-2532	40	3	diagnosis	diagnosis	NOUN
dti-2532	40	4	of	of	ADP
dti-2532	40	5	sepsis	sepsis	NOUN
dti-2532	40	6	and	and	CCONJ
dti-2532	40	7	typhoid	typhoid	NOUN
dti-2532	40	8	fever	fever	NOUN
dti-2532	40	9	are	be	AUX
dti-2532	40	10	urgently	urgently	ADV
dti-2532	40	11	required	require	VERB
dti-2532	40	12	to	to	PART
dti-2532	40	13	contain	contain	VERB
dti-2532	40	14	spread	spread	NOUN
dti-2532	40	15	of	of	ADP
dti-2532	40	16	resistant	resistant	ADJ
dti-2532	40	17	infections	infection	NOUN
dti-2532	40	18	and	and	CCONJ
dti-2532	40	19	reduce	reduce	VERB
dti-2532	40	20	morbidity	morbidity	NOUN
dti-2532	40	21	and	and	CCONJ
dti-2532	40	22	mortality	mortality	NOUN
dti-2532	40	23	,	,	PUNCT
dti-2532	40	24	especially	especially	ADV
dti-2532	40	25	in	in	ADP
dti-2532	40	26	neonatal	neonatal	ADJ
dti-2532	40	27	sepsis	sepsis	NOUN
dti-2532	40	28	.	.	PUNCT
dti-2532	41	1	typhoid	typhoid	NOUN
dti-2532	41	2	and	and	CCONJ
dti-2532	41	3	enteric	enteric	ADJ
dti-2532	41	4	fever	fever	NOUN
dti-2532	41	5	are	be	AUX
dti-2532	41	6	major	major	ADJ
dti-2532	41	7	concerns	concern	NOUN
dti-2532	41	8	for	for	ADP
dti-2532	41	9	lmics	lmic	NOUN
dti-2532	41	10	with	with	ADP
dti-2532	41	11	poor	poor	ADJ
dti-2532	41	12	sanitation	sanitation	NOUN
dti-2532	41	13	practices	practice	NOUN
dti-2532	41	14	.	.	PUNCT
dti-2532	42	1	rapid	rapid	ADJ
dti-2532	42	2	diagnostic	diagnostic	ADJ
dti-2532	42	3	tests	test	NOUN
dti-2532	42	4	for	for	ADP
dti-2532	42	5	utis	utis	NOUN
dti-2532	42	6	,	,	PUNCT
dti-2532	42	7	fever	fever	NOUN
dti-2532	42	8	,	,	PUNCT
dti-2532	42	9	and	and	CCONJ
dti-2532	42	10	respiratory	respiratory	ADJ
dti-2532	42	11	infections	infection	NOUN
dti-2532	42	12	(	(	PUNCT
dti-2532	42	13	lower	low	ADJ
dti-2532	42	14	and	and	CCONJ
dti-2532	42	15	upper	upper	ADJ
dti-2532	42	16	tract	tract	NOUN
dti-2532	42	17	)	)	PUNCT
dti-2532	42	18	are	be	AUX
dti-2532	42	19	another	another	DET
dti-2532	42	20	unmet	unmet	NOUN
dti-2532	42	21	need	need	NOUN
dti-2532	42	22	,	,	PUNCT
dti-2532	42	23	where	where	SCONJ
dti-2532	42	24	empirical	empirical	ADJ
dti-2532	42	25	treatments	treatment	NOUN
dti-2532	42	26	result	result	VERB
dti-2532	42	27	in	in	ADP
dti-2532	42	28	heavy	heavy	ADJ
dti-2532	42	29	misuse	misuse	NOUN
dti-2532	42	30	of	of	ADP
dti-2532	42	31	antibiotics	antibiotic	NOUN
dti-2532	42	32	.	.	PUNCT
dti-2532	43	1	global	global	ADJ
dti-2532	43	2	burden	burden	NOUN
dti-2532	43	3	study	study	NOUN
dti-2532	43	4	in	in	ADP
dti-2532	43	5	2019	2019	NUM
dti-2532	43	6	has	have	AUX
dti-2532	43	7	also	also	ADV
dti-2532	43	8	reported	report	VERB
dti-2532	43	9	the	the	DET
dti-2532	43	10	dominance	dominance	NOUN
dti-2532	43	11	of	of	ADP
dti-2532	43	12	lower	low	ADJ
dti-2532	43	13	respiratory	respiratory	ADJ
dti-2532	43	14	infections	infection	NOUN
dti-2532	43	15	,	,	PUNCT
dti-2532	43	16	bsis	bsis	NOUN
dti-2532	43	17	,	,	PUNCT
dti-2532	43	18	and	and	CCONJ
dti-2532	43	19	intra	intra	ADJ
dti-2532	43	20	-	-	ADJ
dti-2532	43	21	abdominal	abdominal	ADJ
dti-2532	43	22	infections	infection	NOUN
dti-2532	43	23	as	as	ADP
dti-2532	43	24	major	major	ADJ
dti-2532	43	25	infections	infection	NOUN
dti-2532	43	26	attributable	attributable	ADJ
dti-2532	43	27	to	to	ADP
dti-2532	43	28	amr	amr	PROPN
dti-2532	43	29	(	(	PUNCT
dti-2532	43	30	3	3	NUM
dti-2532	43	31	)	)	PUNCT
dti-2532	43	32	.	.	PUNCT
dti-2532	44	1	over	over	ADP
dti-2532	44	2	the	the	DET
dti-2532	44	3	last	last	ADJ
dti-2532	44	4	decade	decade	NOUN
dti-2532	44	5	,	,	PUNCT
dti-2532	44	6	several	several	ADJ
dti-2532	44	7	molecular	molecular	ADJ
dti-2532	44	8	diagnostics	diagnostic	NOUN
dti-2532	44	9	have	have	AUX
dti-2532	44	10	been	be	AUX
dti-2532	44	11	developed	develop	VERB
dti-2532	44	12	for	for	ADP
dti-2532	44	13	pathogen	pathogen	NOUN
dti-2532	44	14	identification	identification	NOUN
dti-2532	44	15	and	and	CCONJ
dti-2532	44	16	detection	detection	NOUN
dti-2532	44	17	of	of	ADP
dti-2532	44	18	genes(s	genes(s	NOUN
dti-2532	44	19	)	)	PUNCT
dti-2532	44	20	or	or	CCONJ
dti-2532	44	21	gene	gene	NOUN
dti-2532	44	22	mutations	mutation	NOUN
dti-2532	44	23	for	for	ADP
dti-2532	44	24	presence	presence	NOUN
dti-2532	44	25	or	or	CCONJ
dti-2532	44	26	absence	absence	NOUN
dti-2532	44	27	of	of	ADP
dti-2532	44	28	resistance	resistance	NOUN
dti-2532	44	29	to	to	ADP
dti-2532	44	30	antimicrobials	antimicrobial	NOUN
dti-2532	44	31	(	(	PUNCT
dti-2532	44	32	19	19	NUM
dti-2532	44	33	)	)	PUNCT
dti-2532	44	34	.	.	PUNCT
dti-2532	45	1	despite	despite	SCONJ
dti-2532	45	2	the	the	DET
dti-2532	45	3	expedited	expedite	VERB
dti-2532	45	4	diagnosis	diagnosis	NOUN
dti-2532	45	5	,	,	PUNCT
dti-2532	45	6	these	these	DET
dti-2532	45	7	tests	test	NOUN
dti-2532	45	8	are	be	AUX
dti-2532	45	9	expensive	expensive	ADJ
dti-2532	45	10	and	and	CCONJ
dti-2532	45	11	need	need	VERB
dti-2532	45	12	infrastructure	infrastructure	NOUN
dti-2532	45	13	and	and	CCONJ
dti-2532	45	14	trained	train	VERB
dti-2532	45	15	resources	resource	NOUN
dti-2532	45	16	to	to	PART
dti-2532	45	17	provide	provide	VERB
dti-2532	45	18	results	result	NOUN
dti-2532	45	19	,	,	PUNCT
dti-2532	45	20	thus	thus	ADV
dti-2532	45	21	limiting	limit	VERB
dti-2532	45	22	their	their	PRON
dti-2532	45	23	use	use	NOUN
dti-2532	45	24	in	in	ADP
dti-2532	45	25	resource	resource	NOUN
dti-2532	45	26	-	-	PUNCT
dti-2532	45	27	limiting	limit	VERB
dti-2532	45	28	settings	setting	NOUN
dti-2532	45	29	.	.	PUNCT
dti-2532	46	1	in	in	ADP
dti-2532	46	2	lmics	lmic	NOUN
dti-2532	46	3	,	,	PUNCT
dti-2532	46	4	indigenously	indigenously	ADV
dti-2532	46	5	developed	develop	VERB
dti-2532	46	6	low	low	ADJ
dti-2532	46	7	-	-	PUNCT
dti-2532	46	8	cost	cost	NOUN
dti-2532	46	9	diagnostics	diagnostic	NOUN
dti-2532	46	10	have	have	VERB
dti-2532	46	11	potential	potential	NOUN
dti-2532	46	12	to	to	PART
dti-2532	46	13	fill	fill	VERB
dti-2532	46	14	this	this	DET
dti-2532	46	15	diagnostic	diagnostic	ADJ
dti-2532	46	16	gap	gap	NOUN
dti-2532	46	17	and	and	CCONJ
dti-2532	46	18	help	help	NOUN
dti-2532	46	19	in	in	ADP
dti-2532	46	20	containing	contain	VERB
dti-2532	46	21	amr	amr	NOUN
dti-2532	46	22	(	(	PUNCT
dti-2532	46	23	18	18	NUM
dti-2532	46	24	)	)	PUNCT
dti-2532	46	25	.	.	PUNCT
dti-2532	47	1	however	however	ADV
dti-2532	47	2	,	,	PUNCT
dti-2532	47	3	indigenous	indigenous	ADJ
dti-2532	47	4	efforts	effort	NOUN
dti-2532	47	5	in	in	ADP
dti-2532	47	6	developing	develop	VERB
dti-2532	47	7	new	new	ADJ
dti-2532	47	8	diagnostics	diagnostic	NOUN
dti-2532	47	9	for	for	ADP
dti-2532	47	10	amr	amr	NOUN
dti-2532	47	11	need	need	NOUN
dti-2532	47	12	to	to	PART
dti-2532	47	13	be	be	AUX
dti-2532	47	14	supported	support	VERB
dti-2532	47	15	and	and	CCONJ
dti-2532	47	16	guided	guide	VERB
dti-2532	47	17	by	by	ADP
dti-2532	47	18	delineating	delineate	VERB
dti-2532	47	19	the	the	DET
dti-2532	47	20	local	local	ADJ
dti-2532	47	21	priorities	priority	NOUN
dti-2532	47	22	and	and	CCONJ
dti-2532	47	23	facilitators	facilitator	NOUN
dti-2532	47	24	as	as	ADP
dti-2532	47	25	per	per	ADP
dti-2532	47	26	country	country	NOUN
dti-2532	47	27	’s	’s	PART
dti-2532	47	28	disease	disease	NOUN
dti-2532	47	29	burden	burden	NOUN
dti-2532	47	30	and	and	CCONJ
dti-2532	47	31	healthcare	healthcare	NOUN
dti-2532	47	32	requirements	requirement	NOUN
dti-2532	47	33	.	.	PUNCT
dti-2532	48	1	need	need	NOUN
dti-2532	48	2	of	of	ADP
dti-2532	48	3	new	new	ADJ
dti-2532	48	4	and	and	CCONJ
dti-2532	48	5	reformulated	reformulate	VERB
dti-2532	48	6	antimicrobials	antimicrobial	NOUN
dti-2532	48	7	and	and	CCONJ
dti-2532	48	8	alternatives	alternative	NOUN
dti-2532	48	9	the	the	DET
dti-2532	48	10	reliance	reliance	NOUN
dti-2532	48	11	on	on	ADP
dti-2532	48	12	new	new	ADJ
dti-2532	48	13	drugs	drug	NOUN
dti-2532	48	14	or	or	CCONJ
dti-2532	48	15	combinations	combination	NOUN
dti-2532	48	16	to	to	PART
dti-2532	48	17	fight	fight	VERB
dti-2532	48	18	amr	amr	NOUN
dti-2532	48	19	will	will	AUX
dti-2532	48	20	only	only	ADV
dti-2532	48	21	provide	provide	VERB
dti-2532	48	22	momentary	momentary	ADJ
dti-2532	48	23	relief	relief	NOUN
dti-2532	48	24	as	as	SCONJ
dti-2532	48	25	pathogens	pathogen	NOUN
dti-2532	48	26	will	will	AUX
dti-2532	48	27	evolve	evolve	VERB
dti-2532	48	28	mechanisms	mechanism	NOUN
dti-2532	48	29	to	to	PART
dti-2532	48	30	acquire	acquire	VERB
dti-2532	48	31	resistance	resistance	NOUN
dti-2532	48	32	to	to	ADP
dti-2532	48	33	antimicrobials	antimicrobial	NOUN
dti-2532	48	34	.	.	PUNCT
dti-2532	49	1	analyzing	analyze	VERB
dti-2532	49	2	and	and	CCONJ
dti-2532	49	3	reducing	reduce	VERB
dti-2532	49	4	antibiotic	antibiotic	ADJ
dti-2532	49	5	consumptions	consumption	NOUN
dti-2532	49	6	across	across	ADP
dti-2532	49	7	human	human	ADJ
dti-2532	49	8	and	and	CCONJ
dti-2532	49	9	animal	animal	NOUN
dti-2532	49	10	husbandry	husbandry	NOUN
dti-2532	49	11	sectors	sector	NOUN
dti-2532	49	12	,	,	PUNCT
dti-2532	49	13	research	research	NOUN
dti-2532	49	14	on	on	ADP
dti-2532	49	15	intervention	intervention	NOUN
dti-2532	49	16	strategies	strategy	NOUN
dti-2532	49	17	and	and	CCONJ
dti-2532	49	18	resistance	resistance	NOUN
dti-2532	49	19	rates	rate	NOUN
dti-2532	49	20	can	can	AUX
dti-2532	49	21	help	help	VERB
dti-2532	49	22	in	in	ADP
dti-2532	49	23	tailoring	tailor	VERB
dti-2532	49	24	strategies	strategy	NOUN
dti-2532	49	25	and	and	CCONJ
dti-2532	49	26	infection	infection	NOUN
dti-2532	49	27	-	-	PUNCT
dti-2532	49	28	specific	specific	ADJ
dti-2532	49	29	treatment	treatment	NOUN
dti-2532	49	30	guidelines	guideline	NOUN
dti-2532	49	31	.	.	PUNCT
dti-2532	50	1	the	the	DET
dti-2532	50	2	existing	exist	VERB
dti-2532	50	3	antibiotics	antibiotic	NOUN
dti-2532	50	4	also	also	ADV
dti-2532	50	5	need	need	VERB
dti-2532	50	6	to	to	PART
dti-2532	50	7	be	be	AUX
dti-2532	50	8	utilized	utilize	VERB
dti-2532	50	9	for	for	ADP
dti-2532	50	10	developing	develop	VERB
dti-2532	50	11	new	new	ADJ
dti-2532	50	12	formulations	formulation	NOUN
dti-2532	50	13	to	to	PART
dti-2532	50	14	improve	improve	VERB
dti-2532	50	15	patient	patient	ADJ
dti-2532	50	16	outcomes	outcome	NOUN
dti-2532	50	17	.	.	PUNCT
dti-2532	51	1	there	there	PRON
dti-2532	51	2	is	be	VERB
dti-2532	51	3	a	a	DET
dti-2532	51	4	need	need	NOUN
dti-2532	51	5	to	to	PART
dti-2532	51	6	determine	determine	VERB
dti-2532	51	7	top	top	ADJ
dti-2532	51	8	combinations	combination	NOUN
dti-2532	51	9	of	of	ADP
dti-2532	51	10	antibiotics	antibiotic	NOUN
dti-2532	51	11	for	for	ADP
dti-2532	51	12	bsi	bsi	PROPN
dti-2532	51	13	and	and	CCONJ
dti-2532	51	14	study	study	VERB
dti-2532	51	15	the	the	DET
dti-2532	51	16	efficacy	efficacy	NOUN
dti-2532	51	17	of	of	ADP
dti-2532	51	18	these	these	DET
dti-2532	51	19	combinations	combination	NOUN
dti-2532	51	20	,	,	PUNCT
dti-2532	51	21	preferably	preferably	ADV
dti-2532	51	22	with	with	ADP
dti-2532	51	23	contemporary	contemporary	ADJ
dti-2532	51	24	isolates	isolate	NOUN
dti-2532	51	25	to	to	PART
dti-2532	51	26	provide	provide	VERB
dti-2532	51	27	effective	effective	ADJ
dti-2532	51	28	combinations	combination	NOUN
dti-2532	51	29	for	for	ADP
dti-2532	51	30	the	the	DET
dti-2532	51	31	treatment	treatment	NOUN
dti-2532	51	32	of	of	ADP
dti-2532	51	33	resistant	resistant	ADJ
dti-2532	51	34	infections	infection	NOUN
dti-2532	51	35	.	.	PUNCT
dti-2532	52	1	pharmacokinetic	pharmacokinetic	ADJ
dti-2532	52	2	/	/	SYM
dti-2532	52	3	pharmacodynamic	pharmacodynamic	ADJ
dti-2532	52	4	(	(	PUNCT
dti-2532	52	5	pk	pk	NOUN
dti-2532	52	6	/	/	SYM
dti-2532	52	7	pd	pd	NOUN
dti-2532	52	8	)	)	PUNCT
dti-2532	52	9	and	and	CCONJ
dti-2532	52	10	safety	safety	NOUN
dti-2532	52	11	data	datum	NOUN
dti-2532	52	12	on	on	ADP
dti-2532	52	13	antibiotics	antibiotic	NOUN
dti-2532	52	14	and	and	CCONJ
dti-2532	52	15	their	their	PRON
dti-2532	52	16	combinations	combination	NOUN
dti-2532	52	17	in	in	ADP
dti-2532	52	18	different	different	ADJ
dti-2532	52	19	age	age	NOUN
dti-2532	52	20	groups	group	NOUN
dti-2532	52	21	are	be	AUX
dti-2532	52	22	essential	essential	ADJ
dti-2532	52	23	to	to	PART
dti-2532	52	24	effectively	effectively	ADV
dti-2532	52	25	treat	treat	VERB
dti-2532	52	26	resistant	resistant	ADJ
dti-2532	52	27	infections	infection	NOUN
dti-2532	52	28	.	.	PUNCT
dti-2532	53	1	it	it	PRON
dti-2532	53	2	is	be	AUX
dti-2532	53	3	also	also	ADV
dti-2532	53	4	imperative	imperative	ADJ
dti-2532	53	5	to	to	PART
dti-2532	53	6	understand	understand	VERB
dti-2532	53	7	that	that	SCONJ
dti-2532	53	8	the	the	DET
dti-2532	53	9	need	need	NOUN
dti-2532	53	10	for	for	ADP
dti-2532	53	11	new	new	ADJ
dti-2532	53	12	antibiotics	antibiotic	NOUN
dti-2532	53	13	for	for	ADP
dti-2532	53	14	lmic	lmic	ADJ
dti-2532	53	15	is	be	AUX
dti-2532	53	16	different	different	ADJ
dti-2532	53	17	from	from	ADP
dti-2532	53	18	those	those	PRON
dti-2532	53	19	of	of	ADP
dti-2532	53	20	high	high	ADJ
dti-2532	53	21	-	-	PUNCT
dti-2532	53	22	income	income	NOUN
dti-2532	53	23	countries	country	NOUN
dti-2532	53	24	as	as	ADP
dti-2532	53	25	in	in	ADP
dti-2532	53	26	countries	country	NOUN
dti-2532	53	27	like	like	ADP
dti-2532	53	28	india	india	PROPN
dti-2532	53	29	,	,	PUNCT
dti-2532	53	30	for	for	ADP
dti-2532	53	31	example	example	NOUN
dti-2532	53	32	,	,	PUNCT
dti-2532	53	33	predominant	predominant	ADJ
dti-2532	53	34	carbapenemase	carbapenemase	NOUN
dti-2532	53	35	present	present	ADJ
dti-2532	53	36	in	in	ADP
dti-2532	53	37	gram	gram	NOUN
dti-2532	53	38	-	-	PUNCT
dti-2532	53	39	negative	negative	ADJ
dti-2532	53	40	isolates	isolate	NOUN
dti-2532	53	41	are	be	AUX
dti-2532	53	42	metallo	metallo	ADJ
dti-2532	53	43	-	-	PUNCT
dti-2532	53	44	β	β	NOUN
dti-2532	53	45	-	-	NOUN
dti-2532	53	46	lactamases	lactamase	NOUN
dti-2532	53	47	(	(	PUNCT
dti-2532	53	48	ndm	ndm	PROPN
dti-2532	53	49	,	,	PUNCT
dti-2532	53	50	vim	vim	PROPN
dti-2532	53	51	)	)	PUNCT
dti-2532	53	52	and	and	CCONJ
dti-2532	53	53	not	not	PART
dti-2532	53	54	kpc	kpc	NOUN
dti-2532	53	55	(	(	PUNCT
dti-2532	53	56	7	7	NUM
dti-2532	53	57	)	)	PUNCT
dti-2532	53	58	.	.	PUNCT
dti-2532	54	1	this	this	PRON
dti-2532	54	2	also	also	ADV
dti-2532	54	3	holds	hold	VERB
dti-2532	54	4	true	true	ADJ
dti-2532	54	5	for	for	ADP
dti-2532	54	6	p.	p.	NOUN
dti-2532	54	7	aeruginosa	aeruginosa	PROPN
dti-2532	54	8	as	as	SCONJ
dti-2532	54	9	the	the	DET
dti-2532	54	10	newer	new	ADJ
dti-2532	54	11	drugs	drug	NOUN
dti-2532	54	12	for	for	ADP
dti-2532	54	13	gramnegatives	gramnegative	NOUN
dti-2532	54	14	(	(	PUNCT
dti-2532	54	15	ceftazidime	ceftazidime	NOUN
dti-2532	54	16	-	-	PUNCT
dti-2532	54	17	avibactam	avibactam	NOUN
dti-2532	54	18	,	,	PUNCT
dti-2532	54	19	imipenem	imipenem	ADJ
dti-2532	54	20	-	-	PUNCT
dti-2532	54	21	relebactam	relebactam	NOUN
dti-2532	54	22	,	,	PUNCT
dti-2532	54	23	and	and	CCONJ
dti-2532	54	24	meropenem	meropenem	NOUN
dti-2532	54	25	-	-	PUNCT
dti-2532	54	26	vaborbactam	vaborbactam	NOUN
dti-2532	54	27	)	)	PUNCT
dti-2532	54	28	do	do	AUX
dti-2532	54	29	not	not	PART
dti-2532	54	30	have	have	VERB
dti-2532	54	31	activity	activity	NOUN
dti-2532	54	32	against	against	ADP
dti-2532	54	33	metallo	metallo	PROPN
dti-2532	54	34	-	-	PUNCT
dti-2532	54	35	β	β	NOUN
dti-2532	54	36	-	-	NOUN
dti-2532	54	37	lactamases	lactamase	NOUN
dti-2532	54	38	.	.	PUNCT
dti-2532	55	1	this	this	PRON
dti-2532	55	2	becomes	become	VERB
dti-2532	55	3	an	an	DET
dti-2532	55	4	important	important	ADJ
dti-2532	55	5	aspect	aspect	NOUN
dti-2532	55	6	for	for	ADP
dti-2532	55	7	drug	drug	NOUN
dti-2532	55	8	developers	developer	NOUN
dti-2532	55	9	for	for	ADP
dti-2532	55	10	consideration	consideration	NOUN
dti-2532	55	11	with	with	ADP
dti-2532	55	12	regard	regard	NOUN
dti-2532	55	13	to	to	ADP
dti-2532	55	14	lmics	lmic	NOUN
dti-2532	55	15	.	.	PUNCT
dti-2532	56	1	low	low	ADJ
dti-2532	56	2	-	-	PUNCT
dti-2532	56	3	cost	cost	NOUN
dti-2532	56	4	solutions	solution	NOUN
dti-2532	56	5	are	be	AUX
dti-2532	56	6	therefore	therefore	ADV
dti-2532	56	7	urgently	urgently	ADV
dti-2532	56	8	needed	need	VERB
dti-2532	56	9	to	to	PART
dti-2532	56	10	preserve	preserve	VERB
dti-2532	56	11	the	the	DET
dti-2532	56	12	efficacy	efficacy	NOUN
dti-2532	56	13	of	of	ADP
dti-2532	56	14	available	available	ADJ
dti-2532	56	15	antibiotics	antibiotic	NOUN
dti-2532	56	16	/	/	SYM
dti-2532	56	17	antibiotic	antibiotic	ADJ
dti-2532	56	18	alternatives	alternative	NOUN
dti-2532	56	19	such	such	ADJ
dti-2532	56	20	as	as	ADP
dti-2532	56	21	virulence	virulence	NOUN
dti-2532	56	22	blockers	blocker	NOUN
dti-2532	56	23	,	,	PUNCT
dti-2532	56	24	immune	immune	ADJ
dti-2532	56	25	modulators	modulator	NOUN
dti-2532	56	26	,	,	PUNCT
dti-2532	56	27	vaccines	vaccine	NOUN
dti-2532	56	28	,	,	PUNCT
dti-2532	56	29	etc	etc	X
dti-2532	56	30	.	.	X
dti-2532	56	31	research	research	NOUN
dti-2532	56	32	efforts	effort	NOUN
dti-2532	56	33	need	need	VERB
dti-2532	56	34	to	to	PART
dti-2532	56	35	be	be	AUX
dti-2532	56	36	prioritized	prioritize	VERB
dti-2532	56	37	for	for	ADP
dti-2532	56	38	new	new	ADJ
dti-2532	56	39	treatment	treatment	NOUN
dti-2532	56	40	strategies	strategy	NOUN
dti-2532	56	41	such	such	ADJ
dti-2532	56	42	as	as	ADP
dti-2532	56	43	re	re	NOUN
dti-2532	56	44	-	-	NOUN
dti-2532	56	45	appropriation	appropriation	NOUN
dti-2532	56	46	of	of	ADP
dti-2532	56	47	old	old	ADJ
dti-2532	56	48	drugs	drug	NOUN
dti-2532	56	49	,	,	PUNCT
dti-2532	56	50	delivery	delivery	NOUN
dti-2532	56	51	strategies	strategy	NOUN
dti-2532	56	52	and	and	CCONJ
dti-2532	56	53	for	for	ADP
dti-2532	56	54	resistance	resistance	NOUN
dti-2532	56	55	mechanisms	mechanism	NOUN
dti-2532	56	56	such	such	ADJ
dti-2532	56	57	as	as	ADP
dti-2532	56	58	efflux	efflux	NOUN
dti-2532	56	59	pump	pump	NOUN
dti-2532	56	60	inhibitors	inhibitor	NOUN
dti-2532	56	61	,	,	PUNCT
dti-2532	56	62	and	and	CCONJ
dti-2532	56	63	bacteriophage	bacteriophage	NOUN
dti-2532	56	64	treatment	treatment	NOUN
dti-2532	56	65	.	.	PUNCT
dti-2532	57	1	strengthening	strengthen	VERB
dti-2532	57	2	surveillance	surveillance	NOUN
dti-2532	57	3	of	of	ADP
dti-2532	57	4	drug	drug	NOUN
dti-2532	57	5	-	-	PUNCT
dti-2532	57	6	resistant	resistant	ADJ
dti-2532	57	7	infections	infection	NOUN
dti-2532	57	8	tracking	track	VERB
dti-2532	57	9	resistance	resistance	NOUN
dti-2532	57	10	trends	trend	NOUN
dti-2532	57	11	is	be	AUX
dti-2532	57	12	important	important	ADJ
dti-2532	57	13	to	to	PART
dti-2532	57	14	reduce	reduce	VERB
dti-2532	57	15	the	the	DET
dti-2532	57	16	burden	burden	NOUN
dti-2532	57	17	of	of	ADP
dti-2532	57	18	infections	infection	NOUN
dti-2532	57	19	in	in	ADP
dti-2532	57	20	hospitals	hospital	NOUN
dti-2532	57	21	and	and	CCONJ
dti-2532	57	22	community	community	NOUN
dti-2532	57	23	settings	setting	NOUN
dti-2532	57	24	.	.	PUNCT
dti-2532	58	1	data	datum	NOUN
dti-2532	58	2	generated	generate	VERB
dti-2532	58	3	through	through	ADP
dti-2532	58	4	surveillance	surveillance	NOUN
dti-2532	58	5	can	can	AUX
dti-2532	58	6	be	be	AUX
dti-2532	58	7	used	use	VERB
dti-2532	58	8	in	in	ADP
dti-2532	58	9	defining	define	VERB
dti-2532	58	10	guidance	guidance	NOUN
dti-2532	58	11	for	for	ADP
dti-2532	58	12	treatment	treatment	NOUN
dti-2532	58	13	in	in	ADP
dti-2532	58	14	common	common	ADJ
dti-2532	58	15	syndromes	syndrome	NOUN
dti-2532	58	16	and	and	CCONJ
dti-2532	58	17	diagnosis	diagnosis	NOUN
dti-2532	58	18	of	of	ADP
dti-2532	58	19	infections	infection	NOUN
dti-2532	58	20	.	.	PUNCT
dti-2532	59	1	it	it	PRON
dti-2532	59	2	is	be	AUX
dti-2532	59	3	important	important	ADJ
dti-2532	59	4	to	to	PART
dti-2532	59	5	implement	implement	VERB
dti-2532	59	6	infection	infection	NOUN
dti-2532	59	7	prevention	prevention	NOUN
dti-2532	59	8	and	and	CCONJ
dti-2532	59	9	control	control	NOUN
dti-2532	59	10	,	,	PUNCT
dti-2532	59	11	antimicrobial	antimicrobial	ADJ
dti-2532	59	12	stewardship	stewardship	NOUN
dti-2532	59	13	practices	practice	NOUN
dti-2532	59	14	,	,	PUNCT
dti-2532	59	15	and	and	CCONJ
dti-2532	59	16	management	management	NOUN
dti-2532	59	17	of	of	ADP
dti-2532	59	18	resistant	resistant	ADJ
dti-2532	59	19	infections80	infections80	NOUN
dti-2532	60	1	©	©	ADP
dti-2532	60	2	2022	2022	NUM
dti-2532	60	3	the	the	DET
dti-2532	60	4	authors	author	NOUN
dti-2532	60	5	.	.	PUNCT
dti-2532	61	1	drug	drug	NOUN
dti-2532	61	2	target	target	NOUN
dti-2532	61	3	insights	insight	NOUN
dti-2532	61	4	issn	issn	VERB
dti-2532	61	5	1177	1177	NUM
dti-2532	61	6	-	-	SYM
dti-2532	61	7	3928	3928	NUM
dti-2532	61	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2532	61	9	immunization	immunization	NOUN
dti-2532	61	10	program	program	NOUN
dti-2532	61	11	and	and	CCONJ
dti-2532	61	12	reduce	reduce	VERB
dti-2532	61	13	overand	overand	PROPN
dti-2532	61	14	misuse	misuse	NOUN
dti-2532	61	15	of	of	ADP
dti-2532	61	16	antimicrobials	antimicrobial	NOUN
dti-2532	61	17	.	.	PUNCT
dti-2532	62	1	national	national	ADJ
dti-2532	62	2	estimates	estimate	NOUN
dti-2532	62	3	of	of	ADP
dti-2532	62	4	resistant	resistant	ADJ
dti-2532	62	5	infections	infection	NOUN
dti-2532	62	6	,	,	PUNCT
dti-2532	62	7	etiology	etiology	NOUN
dti-2532	62	8	of	of	ADP
dti-2532	62	9	infections	infection	NOUN
dti-2532	62	10	,	,	PUNCT
dti-2532	62	11	type	type	NOUN
dti-2532	62	12	of	of	ADP
dti-2532	62	13	infections	infection	NOUN
dti-2532	62	14	,	,	PUNCT
dti-2532	62	15	and	and	CCONJ
dti-2532	62	16	local	local	ADJ
dti-2532	62	17	resistance	resistance	NOUN
dti-2532	62	18	rates	rate	NOUN
dti-2532	62	19	and	and	CCONJ
dti-2532	62	20	patterns	pattern	NOUN
dti-2532	62	21	can	can	AUX
dti-2532	62	22	be	be	AUX
dti-2532	62	23	utilized	utilize	VERB
dti-2532	62	24	to	to	PART
dti-2532	62	25	set	set	VERB
dti-2532	62	26	research	research	NOUN
dti-2532	62	27	priorities	priority	NOUN
dti-2532	62	28	regarding	regard	VERB
dti-2532	62	29	challenges	challenge	NOUN
dti-2532	62	30	and	and	CCONJ
dti-2532	62	31	opportunities	opportunity	NOUN
dti-2532	62	32	to	to	PART
dti-2532	62	33	tackle	tackle	VERB
dti-2532	62	34	resistant	resistant	ADJ
dti-2532	62	35	pathogens	pathogen	NOUN
dti-2532	62	36	in	in	ADP
dti-2532	62	37	different	different	ADJ
dti-2532	62	38	healthcare	healthcare	NOUN
dti-2532	62	39	and	and	CCONJ
dti-2532	62	40	community	community	NOUN
dti-2532	62	41	settings	setting	NOUN
dti-2532	62	42	.	.	PUNCT
dti-2532	63	1	in	in	ADP
dti-2532	63	2	conclusion	conclusion	NOUN
dti-2532	63	3	,	,	PUNCT
dti-2532	63	4	evidence	evidence	NOUN
dti-2532	63	5	-	-	PUNCT
dti-2532	63	6	based	base	VERB
dti-2532	63	7	treatment	treatment	NOUN
dti-2532	63	8	strategies	strategy	NOUN
dti-2532	63	9	will	will	AUX
dti-2532	63	10	be	be	AUX
dti-2532	63	11	effective	effective	ADJ
dti-2532	63	12	in	in	ADP
dti-2532	63	13	preventing	prevent	VERB
dti-2532	63	14	and	and	CCONJ
dti-2532	63	15	managing	manage	VERB
dti-2532	63	16	resistant	resistant	ADJ
dti-2532	63	17	infections	infection	NOUN
dti-2532	63	18	.	.	PUNCT
dti-2532	64	1	affordable	affordable	ADJ
dti-2532	64	2	and	and	CCONJ
dti-2532	64	3	accessible	accessible	ADJ
dti-2532	64	4	quality	quality	NOUN
dti-2532	64	5	diagnostics	diagnostic	NOUN
dti-2532	64	6	with	with	ADP
dti-2532	64	7	fast	fast	ADJ
dti-2532	64	8	turnaround	turnaround	NOUN
dti-2532	64	9	time	time	NOUN
dti-2532	64	10	will	will	AUX
dti-2532	64	11	help	help	VERB
dti-2532	64	12	in	in	ADP
dti-2532	64	13	enabling	enable	VERB
dti-2532	64	14	better	well	ADJ
dti-2532	64	15	patient	patient	ADJ
dti-2532	64	16	care	care	NOUN
dti-2532	64	17	and	and	CCONJ
dti-2532	64	18	survival	survival	NOUN
dti-2532	64	19	outcomes	outcome	NOUN
dti-2532	64	20	,	,	PUNCT
dti-2532	64	21	thus	thus	ADV
dti-2532	64	22	reducing	reduce	VERB
dti-2532	64	23	economic	economic	ADJ
dti-2532	64	24	burden	burden	NOUN
dti-2532	64	25	on	on	ADP
dti-2532	64	26	healthcare	healthcare	PROPN
dti-2532	64	27	.	.	PUNCT
dti-2532	65	1	disclosures	disclosure	VERB
dti-2532	65	2	conflict	conflict	NOUN
dti-2532	65	3	of	of	ADP
dti-2532	65	4	interest	interest	NOUN
dti-2532	65	5	:	:	PUNCT
dti-2532	65	6	the	the	DET
dti-2532	65	7	authors	author	NOUN
dti-2532	65	8	declare	declare	VERB
dti-2532	65	9	no	no	DET
dti-2532	65	10	conflict	conflict	NOUN
dti-2532	65	11	of	of	ADP
dti-2532	65	12	interest	interest	NOUN
dti-2532	65	13	.	.	PUNCT
dti-2532	66	1	financial	financial	ADJ
dti-2532	66	2	support	support	NOUN
dti-2532	66	3	:	:	PUNCT
dti-2532	66	4	this	this	DET
dti-2532	66	5	research	research	NOUN
dti-2532	66	6	received	receive	VERB
dti-2532	66	7	no	no	DET
dti-2532	66	8	specific	specific	ADJ
dti-2532	66	9	grant	grant	NOUN
dti-2532	66	10	from	from	ADP
dti-2532	66	11	any	any	DET
dti-2532	66	12	funding	funding	NOUN
dti-2532	66	13	agency	agency	NOUN
dti-2532	66	14	in	in	ADP
dti-2532	66	15	the	the	DET
dti-2532	66	16	public	public	ADJ
dti-2532	66	17	,	,	PUNCT
dti-2532	66	18	commercial	commercial	ADJ
dti-2532	66	19	,	,	PUNCT
dti-2532	66	20	or	or	CCONJ
dti-2532	66	21	not	not	PART
dti-2532	66	22	-	-	PUNCT
dti-2532	66	23	for	for	ADP
dti-2532	66	24	-	-	PUNCT
dti-2532	66	25	profit	profit	NOUN
dti-2532	66	26	sectors	sector	NOUN
dti-2532	66	27	.	.	PUNCT
dti-2532	67	1	authors	author	NOUN
dti-2532	67	2	contribution	contribution	VERB
dti-2532	67	3	:	:	PUNCT
dti-2532	67	4	all	all	DET
dti-2532	67	5	authors	author	NOUN
dti-2532	67	6	contributed	contribute	VERB
dti-2532	67	7	equally	equally	ADV
dti-2532	67	8	to	to	ADP
dti-2532	67	9	this	this	DET
dti-2532	67	10	manuscript	manuscript	NOUN
dti-2532	67	11	.	.	PUNCT
dti-2532	68	1	references	reference	NOUN
dti-2532	68	2	1	1	NUM
dti-2532	68	3	.	.	PUNCT
dti-2532	69	1	o’neil	o’neil	PROPN
dti-2532	69	2	j.	j.	PROPN
dti-2532	69	3	tackling	tackle	VERB
dti-2532	69	4	drug	drug	NOUN
dti-2532	69	5	-	-	PUNCT
dti-2532	69	6	resistant	resistant	ADJ
dti-2532	69	7	infections	infection	NOUN
dti-2532	69	8	globally	globally	ADV
dti-2532	69	9	:	:	PUNCT
dti-2532	69	10	final	final	ADJ
dti-2532	69	11	report	report	NOUN
dti-2532	69	12	and	and	CCONJ
dti-2532	69	13	recommendations	recommendation	NOUN
dti-2532	69	14	.	.	PUNCT
dti-2532	70	1	the	the	DET
dti-2532	70	2	review	review	NOUN
dti-2532	70	3	on	on	ADP
dti-2532	70	4	antimicrobial	antimicrobial	ADJ
dti-2532	70	5	resistance	resistance	NOUN
dti-2532	70	6	chaired	chair	VERB
dti-2532	70	7	by	by	ADP
dti-2532	70	8	jim	jim	PROPN
dti-2532	70	9	o’neill	o’neill	PROPN
dti-2532	70	10	.	.	PUNCT
dti-2532	71	1	wellcome	wellcome	PROPN
dti-2532	71	2	trust	trust	PROPN
dti-2532	71	3	;	;	PUNCT
dti-2532	71	4	london	london	PROPN
dti-2532	71	5	,	,	PUNCT
dti-2532	71	6	united	united	ADJ
dti-2532	71	7	kingdom	kingdom	PROPN
dti-2532	71	8	:	:	PUNCT
dti-2532	71	9	2016	2016	NUM
dti-2532	71	10	;	;	PUNCT
dti-2532	71	11	1	1	NUM
dti-2532	71	12	:	:	SYM
dti-2532	71	13	84	84	NUM
dti-2532	71	14	.	.	PUNCT
dti-2532	72	1	online	online	INTJ
dti-2532	72	2	.	.	PUNCT
dti-2532	73	1	accessed	access	VERB
dti-2532	73	2	november	november	PROPN
dti-2532	73	3	2022	2022	NUM
dti-2532	73	4	.	.	PUNCT
dti-2532	74	1	2	2	X
dti-2532	74	2	.	.	X
dti-2532	74	3	pokharel	pokharel	PROPN
dti-2532	74	4	s	s	PROPN
dti-2532	74	5	,	,	PUNCT
dti-2532	74	6	raut	raut	PROPN
dti-2532	74	7	s	s	PROPN
dti-2532	74	8	,	,	PUNCT
dti-2532	74	9	adhikari	adhikari	PROPN
dti-2532	74	10	b.	b.	PROPN
dti-2532	74	11	tackling	tackle	VERB
dti-2532	74	12	antimicrobial	antimicrobial	ADJ
dti-2532	74	13	resistance	resistance	NOUN
dti-2532	74	14	in	in	ADP
dti-2532	74	15	low	low	ADJ
dti-2532	74	16	-	-	PUNCT
dti-2532	74	17	income	income	NOUN
dti-2532	74	18	and	and	CCONJ
dti-2532	74	19	middle	middle	ADJ
dti-2532	74	20	-	-	PUNCT
dti-2532	74	21	income	income	NOUN
dti-2532	74	22	countries	country	NOUN
dti-2532	74	23	.	.	PUNCT
dti-2532	75	1	bmj	bmj	PROPN
dti-2532	75	2	glob	glob	NOUN
dti-2532	75	3	health	health	NOUN
dti-2532	75	4	.	.	PUNCT
dti-2532	76	1	2019;4(6):e002104	2019;4(6):e002104	X
dti-2532	76	2	.	.	PUNCT
dti-2532	77	1	crossref	crossref	PROPN
dti-2532	77	2	pubmed	pubmed	PROPN
dti-2532	77	3	3	3	NUM
dti-2532	77	4	.	.	PUNCT
dti-2532	77	5	antimicrobial	antimicrobial	ADJ
dti-2532	77	6	resistance	resistance	NOUN
dti-2532	77	7	collaborators	collaborator	NOUN
dti-2532	77	8	.	.	PUNCT
dti-2532	78	1	global	global	ADJ
dti-2532	78	2	burden	burden	NOUN
dti-2532	78	3	of	of	ADP
dti-2532	78	4	bacterial	bacterial	ADJ
dti-2532	78	5	antimicrobial	antimicrobial	ADJ
dti-2532	78	6	resistance	resistance	NOUN
dti-2532	78	7	in	in	ADP
dti-2532	78	8	2019	2019	NUM
dti-2532	78	9	:	:	PUNCT
dti-2532	78	10	a	a	DET
dti-2532	78	11	systematic	systematic	ADJ
dti-2532	78	12	analysis	analysis	NOUN
dti-2532	78	13	.	.	PUNCT
dti-2532	79	1	lancet	lancet	NOUN
dti-2532	79	2	.	.	PUNCT
dti-2532	80	1	2022;399(10325):629	2022;399(10325):629	NUM
dti-2532	80	2	-	-	SYM
dti-2532	80	3	655	655	NUM
dti-2532	80	4	.	.	PUNCT
dti-2532	81	1	crossref	crossref	PROPN
dti-2532	81	2	pubmed	pubmed	PROPN
dti-2532	81	3	4	4	PROPN
dti-2532	81	4	.	.	PUNCT
dti-2532	82	1	gandra	gandra	PROPN
dti-2532	82	2	s	s	PROPN
dti-2532	82	3	,	,	PUNCT
dti-2532	82	4	tseng	tseng	PROPN
dti-2532	82	5	kk	kk	PROPN
dti-2532	82	6	,	,	PUNCT
dti-2532	82	7	arora	arora	PROPN
dti-2532	82	8	a	a	PROPN
dti-2532	82	9	,	,	PUNCT
dti-2532	82	10	et	et	PROPN
dti-2532	82	11	al	al	PROPN
dti-2532	82	12	.	.	PUNCT
dti-2532	83	1	the	the	DET
dti-2532	83	2	mortality	mortality	NOUN
dti-2532	83	3	burden	burden	NOUN
dti-2532	83	4	of	of	ADP
dti-2532	83	5	multidrug	multidrug	NOUN
dti-2532	83	6	-	-	PUNCT
dti-2532	83	7	resistant	resistant	ADJ
dti-2532	83	8	pathogens	pathogen	NOUN
dti-2532	83	9	in	in	ADP
dti-2532	83	10	india	india	PROPN
dti-2532	83	11	:	:	PUNCT
dti-2532	83	12	a	a	DET
dti-2532	83	13	retrospective	retrospective	ADJ
dti-2532	83	14	,	,	PUNCT
dti-2532	83	15	observational	observational	ADJ
dti-2532	83	16	study	study	NOUN
dti-2532	83	17	.	.	PUNCT
dti-2532	84	1	clin	clin	PROPN
dti-2532	84	2	infect	infect	PROPN
dti-2532	84	3	dis	dis	PROPN
dti-2532	84	4	.	.	PUNCT
dti-2532	85	1	2019;69(4):563	2019;69(4):563	NUM
dti-2532	85	2	-	-	SYM
dti-2532	85	3	570	570	NUM
dti-2532	85	4	.	.	PUNCT
dti-2532	86	1	crossref	crossref	PROPN
dti-2532	86	2	pubmed	pubmed	PROPN
dti-2532	86	3	5	5	NUM
dti-2532	86	4	.	.	PUNCT
dti-2532	87	1	sulis	sulis	PROPN
dti-2532	87	2	g	g	NOUN
dti-2532	87	3	,	,	PUNCT
dti-2532	87	4	sayood	sayood	NOUN
dti-2532	87	5	s	s	PART
dti-2532	87	6	,	,	PUNCT
dti-2532	87	7	gandra	gandra	PROPN
dti-2532	87	8	s.	s.	PROPN
dti-2532	87	9	antimicrobial	antimicrobial	PROPN
dti-2532	87	10	resistance	resistance	NOUN
dti-2532	87	11	in	in	ADP
dti-2532	87	12	low	low	ADJ
dti-2532	87	13	and	and	CCONJ
dti-2532	87	14	middle	middle	ADJ
dti-2532	87	15	-	-	PUNCT
dti-2532	87	16	income	income	NOUN
dti-2532	87	17	countries	country	NOUN
dti-2532	87	18	:	:	PUNCT
dti-2532	87	19	current	current	ADJ
dti-2532	87	20	status	status	NOUN
dti-2532	87	21	and	and	CCONJ
dti-2532	87	22	future	future	ADJ
dti-2532	87	23	directions	direction	NOUN
dti-2532	87	24	.	.	PUNCT
dti-2532	88	1	expert	expert	NOUN
dti-2532	88	2	rev	rev	VERB
dti-2532	88	3	anti	anti	PROPN
dti-2532	88	4	infect	infect	VERB
dti-2532	88	5	ther	ther	ADV
dti-2532	88	6	.	.	PUNCT
dti-2532	89	1	2022;20(2):147	2022;20(2):147	NUM
dti-2532	89	2	-	-	PUNCT
dti-2532	89	3	160	160	NUM
dti-2532	89	4	.	.	PUNCT
dti-2532	90	1	crossref	crossref	PROPN
dti-2532	90	2	pubmed	pubmed	PROPN
dti-2532	90	3	6	6	NUM
dti-2532	90	4	.	.	PUNCT
dti-2532	91	1	laxminarayan	laxminarayan	PROPN
dti-2532	91	2	r	r	PROPN
dti-2532	91	3	,	,	PUNCT
dti-2532	91	4	chaudhury	chaudhury	PROPN
dti-2532	91	5	rr	rr	NOUN
dti-2532	91	6	.	.	PUNCT
dti-2532	92	1	antibiotic	antibiotic	ADJ
dti-2532	92	2	resistance	resistance	NOUN
dti-2532	92	3	in	in	ADP
dti-2532	92	4	india	india	PROPN
dti-2532	92	5	:	:	PUNCT
dti-2532	92	6	drivers	driver	NOUN
dti-2532	92	7	and	and	CCONJ
dti-2532	92	8	opportunities	opportunity	NOUN
dti-2532	92	9	for	for	ADP
dti-2532	92	10	action	action	NOUN
dti-2532	92	11	.	.	PUNCT
dti-2532	93	1	plos	plos	PROPN
dti-2532	93	2	med	med	PROPN
dti-2532	93	3	.	.	PROPN
dti-2532	93	4	2016	2016	NUM
dti-2532	93	5	;	;	PUNCT
dti-2532	94	1	13(3):e1001974	13(3):e1001974	NUM
dti-2532	94	2	.	.	PUNCT
dti-2532	95	1	crossref	crossref	PROPN
dti-2532	95	2	pubmed	pubmed	PROPN
dti-2532	95	3	7	7	PROPN
dti-2532	95	4	.	.	PUNCT
dti-2532	96	1	report	report	NOUN
dti-2532	96	2	a.	a.	PROPN
dti-2532	96	3	antimicrobial	antimicrobial	PROPN
dti-2532	96	4	resistance	resistance	NOUN
dti-2532	96	5	research	research	NOUN
dti-2532	96	6	and	and	CCONJ
dti-2532	96	7	surveillance	surveillance	NOUN
dti-2532	96	8	network	network	NOUN
dti-2532	96	9	.	.	PUNCT
dti-2532	97	1	indian	indian	PROPN
dti-2532	97	2	council	council	PROPN
dti-2532	97	3	of	of	ADP
dti-2532	97	4	medical	medical	ADJ
dti-2532	97	5	research	research	NOUN
dti-2532	97	6	;	;	PUNCT
dti-2532	97	7	2021	2021	NUM
dti-2532	97	8	.	.	PUNCT
dti-2532	98	1	online	online	INTJ
dti-2532	98	2	.	.	PUNCT
dti-2532	99	1	8	8	X
dti-2532	99	2	.	.	X
dti-2532	99	3	wen	wen	PROPN
dti-2532	99	4	sch	sch	PROPN
dti-2532	99	5	,	,	PUNCT
dti-2532	99	6	ezure	ezure	VERB
dti-2532	99	7	y	y	PROPN
dti-2532	99	8	,	,	PUNCT
dti-2532	99	9	rolley	rolley	NOUN
dti-2532	99	10	l	l	PROPN
dti-2532	99	11	,	,	PUNCT
dti-2532	99	12	et	et	PROPN
dti-2532	99	13	al	al	PROPN
dti-2532	99	14	.	.	PUNCT
dti-2532	100	1	gram	gram	NOUN
dti-2532	100	2	-	-	PUNCT
dti-2532	100	3	negative	negative	ADJ
dti-2532	100	4	neonatal	neonatal	ADJ
dti-2532	100	5	sepsis	sepsis	NOUN
dti-2532	100	6	in	in	ADP
dti-2532	100	7	lowand	lowand	ADJ
dti-2532	100	8	lower	lower	ADV
dti-2532	100	9	-	-	PUNCT
dti-2532	100	10	middle	middle	ADJ
dti-2532	100	11	-	-	PUNCT
dti-2532	100	12	income	income	NOUN
dti-2532	100	13	countries	country	NOUN
dti-2532	100	14	and	and	CCONJ
dti-2532	100	15	who	who	PRON
dti-2532	100	16	empirical	empirical	ADJ
dti-2532	100	17	antibiotic	antibiotic	ADJ
dti-2532	100	18	recommendations	recommendation	NOUN
dti-2532	100	19	:	:	PUNCT
dti-2532	100	20	a	a	DET
dti-2532	100	21	systematic	systematic	ADJ
dti-2532	100	22	review	review	NOUN
dti-2532	100	23	and	and	CCONJ
dti-2532	100	24	meta	meta	ADJ
dti-2532	100	25	-	-	PUNCT
dti-2532	100	26	analysis	analysis	NOUN
dti-2532	100	27	.	.	PUNCT
dti-2532	101	1	plos	plos	PROPN
dti-2532	101	2	med	med	PROPN
dti-2532	101	3	.	.	PUNCT
dti-2532	102	1	2021;18(9):e1003787	2021;18(9):e1003787	NUM
dti-2532	102	2	.	.	PUNCT
dti-2532	102	3	crossref	crossref	PROPN
dti-2532	102	4	pubmed	pubmed	PROPN
dti-2532	102	5	9	9	PROPN
dti-2532	102	6	.	.	PUNCT
dti-2532	102	7	wahl	wahl	PROPN
dti-2532	102	8	b	b	PROPN
dti-2532	102	9	,	,	PUNCT
dti-2532	102	10	o’brien	o’brien	PROPN
dti-2532	102	11	kl	kl	PROPN
dti-2532	102	12	,	,	PUNCT
dti-2532	102	13	greenbaum	greenbaum	PROPN
dti-2532	102	14	a	a	X
dti-2532	102	15	,	,	PUNCT
dti-2532	102	16	et	et	PROPN
dti-2532	102	17	al	al	PROPN
dti-2532	102	18	.	.	PUNCT
dti-2532	102	19	burden	burden	NOUN
dti-2532	102	20	of	of	ADP
dti-2532	102	21	streptococcus	streptococcus	NOUN
dti-2532	102	22	pneumoniae	pneumoniae	ADJ
dti-2532	102	23	and	and	CCONJ
dti-2532	102	24	haemophilus	haemophilus	ADJ
dti-2532	102	25	influenzae	influenzae	VERB
dti-2532	102	26	type	type	NOUN
dti-2532	102	27	b	b	PROPN
dti-2532	102	28	disease	disease	NOUN
dti-2532	102	29	in	in	ADP
dti-2532	102	30	children	child	NOUN
dti-2532	102	31	in	in	ADP
dti-2532	102	32	the	the	DET
dti-2532	102	33	era	era	NOUN
dti-2532	102	34	of	of	ADP
dti-2532	102	35	conjugate	conjugate	ADJ
dti-2532	102	36	vaccines	vaccine	NOUN
dti-2532	102	37	:	:	PUNCT
dti-2532	102	38	global	global	ADJ
dti-2532	102	39	,	,	PUNCT
dti-2532	102	40	regional	regional	ADJ
dti-2532	102	41	,	,	PUNCT
dti-2532	102	42	and	and	CCONJ
dti-2532	102	43	national	national	ADJ
dti-2532	102	44	estimates	estimate	NOUN
dti-2532	102	45	for	for	ADP
dti-2532	102	46	2000	2000	NUM
dti-2532	102	47	-	-	SYM
dti-2532	102	48	15	15	NUM
dti-2532	102	49	.	.	PUNCT
dti-2532	103	1	lancet	lancet	NOUN
dti-2532	103	2	glob	glob	PROPN
dti-2532	103	3	health	health	NOUN
dti-2532	103	4	.	.	PUNCT
dti-2532	104	1	2018;6(7):e744	2018;6(7):e744	NOUN
dti-2532	104	2	-	-	PUNCT
dti-2532	104	3	e757	e757	PROPN
dti-2532	104	4	.	.	PUNCT
dti-2532	104	5	crossref	crossref	PROPN
dti-2532	104	6	pubmed	pubmed	PROPN
dti-2532	104	7	10	10	PROPN
dti-2532	104	8	.	.	PUNCT
dti-2532	105	1	jajoo	jajoo	PROPN
dti-2532	105	2	m	m	PROPN
dti-2532	105	3	,	,	PUNCT
dti-2532	105	4	manchanda	manchanda	PROPN
dti-2532	105	5	v	v	PROPN
dti-2532	105	6	,	,	PUNCT
dti-2532	105	7	chaurasia	chaurasia	PROPN
dti-2532	105	8	s	s	PROPN
dti-2532	105	9	,	,	PUNCT
dti-2532	105	10	et	et	PROPN
dti-2532	105	11	al	al	PROPN
dti-2532	105	12	;	;	PUNCT
dti-2532	105	13	investigators	investigator	NOUN
dti-2532	105	14	of	of	ADP
dti-2532	105	15	the	the	DET
dti-2532	105	16	delhi	delhi	ADJ
dti-2532	105	17	neonatal	neonatal	ADJ
dti-2532	105	18	infection	infection	NOUN
dti-2532	105	19	study	study	NOUN
dti-2532	105	20	(	(	PUNCT
dti-2532	105	21	denis	denis	PROPN
dti-2532	105	22	)	)	PUNCT
dti-2532	105	23	collaboration	collaboration	NOUN
dti-2532	105	24	,	,	PUNCT
dti-2532	105	25	new	new	ADJ
dti-2532	105	26	delhi	delhi	PROPN
dti-2532	105	27	,	,	PUNCT
dti-2532	105	28	india	india	PROPN
dti-2532	105	29	.	.	PUNCT
dti-2532	106	1	alarming	alarming	ADJ
dti-2532	106	2	rates	rate	NOUN
dti-2532	106	3	of	of	ADP
dti-2532	106	4	antimicrobial	antimicrobial	ADJ
dti-2532	106	5	resistance	resistance	NOUN
dti-2532	106	6	and	and	CCONJ
dti-2532	106	7	fungal	fungal	ADJ
dti-2532	106	8	sepsis	sepsis	NOUN
dti-2532	106	9	in	in	ADP
dti-2532	106	10	outborn	outborn	ADJ
dti-2532	106	11	neonates	neonate	NOUN
dti-2532	106	12	in	in	ADP
dti-2532	106	13	north	north	PROPN
dti-2532	106	14	india	india	PROPN
dti-2532	106	15	.	.	PUNCT
dti-2532	107	1	plos	plos	PROPN
dti-2532	107	2	one	one	NUM
dti-2532	107	3	.	.	PUNCT
dti-2532	108	1	2018;13(6):e0180705	2018;13(6):e0180705	NUM
dti-2532	108	2	.	.	PUNCT
dti-2532	108	3	crossref	crossref	PROPN
dti-2532	108	4	pubmed	pubmed	PROPN
dti-2532	108	5	11	11	NUM
dti-2532	108	6	.	.	PUNCT
dti-2532	109	1	iskandar	iskandar	PROPN
dti-2532	109	2	k	k	PROPN
dti-2532	109	3	,	,	PUNCT
dti-2532	109	4	molinier	molinier	PROPN
dti-2532	109	5	l	l	NOUN
dti-2532	109	6	,	,	PUNCT
dti-2532	109	7	hallit	hallit	VERB
dti-2532	109	8	s	s	PROPN
dti-2532	109	9	,	,	PUNCT
dti-2532	109	10	et	et	PROPN
dti-2532	109	11	al	al	PROPN
dti-2532	109	12	.	.	PROPN
dti-2532	109	13	surveillance	surveillance	NOUN
dti-2532	109	14	of	of	ADP
dti-2532	109	15	antimicrobial	antimicrobial	ADJ
dti-2532	109	16	resistance	resistance	NOUN
dti-2532	109	17	in	in	ADP
dti-2532	109	18	lowand	lowand	ADJ
dti-2532	109	19	middle	middle	ADJ
dti-2532	109	20	-	-	PUNCT
dti-2532	109	21	income	income	NOUN
dti-2532	109	22	countries	country	NOUN
dti-2532	109	23	:	:	PUNCT
dti-2532	109	24	a	a	DET
dti-2532	109	25	scattered	scatter	VERB
dti-2532	109	26	picture	picture	NOUN
dti-2532	109	27	.	.	PUNCT
dti-2532	110	1	antimicrob	antimicrob	PROPN
dti-2532	110	2	resist	resist	VERB
dti-2532	110	3	infect	infect	ADJ
dti-2532	110	4	control	control	NOUN
dti-2532	110	5	.	.	PUNCT
dti-2532	111	1	2021;10(1):63	2021;10(1):63	X
dti-2532	111	2	.	.	PUNCT
dti-2532	111	3	crossref	crossref	PROPN
dti-2532	111	4	pubmed	pubmed	PROPN
dti-2532	111	5	.	.	PROPN
dti-2532	112	1	12	12	NUM
dti-2532	112	2	.	.	PUNCT
dti-2532	113	1	kumar	kumar	PROPN
dti-2532	113	2	sg	sg	PROPN
dti-2532	113	3	,	,	PUNCT
dti-2532	113	4	adithan	adithan	ADP
dti-2532	113	5	c	c	PROPN
dti-2532	113	6	,	,	PUNCT
dti-2532	113	7	harish	harish	PROPN
dti-2532	113	8	bn	bn	PROPN
dti-2532	113	9	,	,	PUNCT
dti-2532	113	10	sujatha	sujatha	PROPN
dti-2532	113	11	s	s	PROPN
dti-2532	113	12	,	,	PUNCT
dti-2532	113	13	roy	roy	PROPN
dti-2532	113	14	g	g	PROPN
dti-2532	113	15	,	,	PUNCT
dti-2532	113	16	malini	malini	PROPN
dti-2532	113	17	a.	a.	PROPN
dti-2532	113	18	antimicrobial	antimicrobial	PROPN
dti-2532	113	19	resistance	resistance	NOUN
dti-2532	113	20	in	in	ADP
dti-2532	113	21	india	india	PROPN
dti-2532	113	22	:	:	PUNCT
dti-2532	113	23	a	a	DET
dti-2532	113	24	review	review	NOUN
dti-2532	113	25	.	.	PUNCT
dti-2532	114	1	j	j	PROPN
dti-2532	114	2	nat	nat	PROPN
dti-2532	114	3	sci	sci	PROPN
dti-2532	114	4	biol	biol	PROPN
dti-2532	114	5	med	me	VERB
dti-2532	114	6	.	.	PUNCT
dti-2532	115	1	2013;4(2):286	2013;4(2):286	NUM
dti-2532	115	2	-	-	SYM
dti-2532	115	3	291	291	NUM
dti-2532	115	4	.	.	PUNCT
dti-2532	116	1	crossref	crossref	PROPN
dti-2532	116	2	pubmed	pubmed	PROPN
dti-2532	116	3	13	13	PROPN
dti-2532	116	4	.	.	PUNCT
dti-2532	117	1	kaur	kaur	PROPN
dti-2532	117	2	a	a	PROPN
dti-2532	117	3	,	,	PUNCT
dti-2532	117	4	gandra	gandra	PROPN
dti-2532	117	5	s	s	PART
dti-2532	117	6	,	,	PUNCT
dti-2532	117	7	gupta	gupta	PROPN
dti-2532	117	8	p	p	NOUN
dti-2532	117	9	,	,	PUNCT
dti-2532	117	10	mehta	mehta	PROPN
dti-2532	117	11	y	y	PROPN
dti-2532	117	12	,	,	PUNCT
dti-2532	117	13	laxminarayan	laxminarayan	PROPN
dti-2532	117	14	r	r	NOUN
dti-2532	117	15	,	,	PUNCT
dti-2532	117	16	sengupta	sengupta	NOUN
dti-2532	117	17	s.	s.	PROPN
dti-2532	117	18	clinical	clinical	ADJ
dti-2532	117	19	outcome	outcome	NOUN
dti-2532	117	20	of	of	ADP
dti-2532	117	21	dual	dual	ADJ
dti-2532	117	22	colistinand	colistinand	NOUN
dti-2532	117	23	carbapenem	carbapenem	PROPN
dti-2532	117	24	resistant	resistant	ADJ
dti-2532	117	25	klebsiella	klebsiella	NOUN
dti-2532	117	26	pneumoniae	pneumoniae	ADJ
dti-2532	117	27	bloodstream	bloodstream	NOUN
dti-2532	117	28	infections	infection	NOUN
dti-2532	117	29	:	:	PUNCT
dti-2532	117	30	a	a	DET
dti-2532	117	31	single	single	ADJ
dti-2532	117	32	-	-	PUNCT
dti-2532	117	33	center	center	NOUN
dti-2532	117	34	retrospective	retrospective	ADJ
dti-2532	117	35	study	study	NOUN
dti-2532	117	36	of	of	ADP
dti-2532	117	37	75	75	NUM
dti-2532	117	38	cases	case	NOUN
dti-2532	117	39	in	in	ADP
dti-2532	117	40	india	india	PROPN
dti-2532	117	41	.	.	PUNCT
dti-2532	117	42	am	be	AUX
dti-2532	117	43	j	j	PROPN
dti-2532	117	44	infect	infect	PROPN
dti-2532	117	45	control	control	NOUN
dti-2532	117	46	.	.	PUNCT
dti-2532	118	1	2017;45(11):1289	2017;45(11):1289	NUM
dti-2532	118	2	-	-	PUNCT
dti-2532	118	3	1291	1291	NUM
dti-2532	118	4	.	.	PUNCT
dti-2532	119	1	crossref	crossref	PROPN
dti-2532	119	2	pubmed	pubmed	PROPN
dti-2532	119	3	14	14	NUM
dti-2532	119	4	.	.	PUNCT
dti-2532	120	1	sharma	sharma	PROPN
dti-2532	120	2	a	a	X
dti-2532	120	3	,	,	PUNCT
dti-2532	120	4	singh	singh	PROPN
dti-2532	120	5	a	a	X
dti-2532	120	6	,	,	PUNCT
dti-2532	120	7	dar	dar	PROPN
dti-2532	120	8	ma	ma	PROPN
dti-2532	120	9	,	,	PUNCT
dti-2532	120	10	et	et	PROPN
dti-2532	120	11	al	al	PROPN
dti-2532	120	12	.	.	PROPN
dti-2532	120	13	menace	menace	NOUN
dti-2532	120	14	of	of	ADP
dti-2532	120	15	antimicrobial	antimicrobial	ADJ
dti-2532	120	16	resistance	resistance	NOUN
dti-2532	120	17	in	in	ADP
dti-2532	120	18	lmics	lmic	NOUN
dti-2532	120	19	:	:	PUNCT
dti-2532	120	20	current	current	ADJ
dti-2532	120	21	surveillance	surveillance	NOUN
dti-2532	120	22	practices	practice	NOUN
dti-2532	120	23	and	and	CCONJ
dti-2532	120	24	control	control	NOUN
dti-2532	120	25	measures	measure	NOUN
dti-2532	120	26	to	to	PART
dti-2532	120	27	tackle	tackle	VERB
dti-2532	120	28	hostility	hostility	NOUN
dti-2532	120	29	.	.	PUNCT
dti-2532	121	1	j	j	PROPN
dti-2532	121	2	infect	infect	VERB
dti-2532	121	3	public	public	ADJ
dti-2532	121	4	health	health	NOUN
dti-2532	121	5	.	.	PUNCT
dti-2532	122	1	2022	2022	NUM
dti-2532	122	2	;	;	PUNCT
dti-2532	122	3	15(2):172	15(2):172	NUM
dti-2532	122	4	-	-	SYM
dti-2532	122	5	181	181	NUM
dti-2532	122	6	.	.	PUNCT
dti-2532	123	1	crossref	crossref	PROPN
dti-2532	123	2	pubmed	pubmed	PROPN
dti-2532	123	3	15	15	PROPN
dti-2532	123	4	.	.	PUNCT
dti-2532	124	1	mathur	mathur	PROPN
dti-2532	124	2	p	p	PROPN
dti-2532	124	3	,	,	PUNCT
dti-2532	124	4	malpiedi	malpiedi	PROPN
dti-2532	124	5	p	p	NOUN
dti-2532	124	6	,	,	PUNCT
dti-2532	124	7	walia	walia	PROPN
dti-2532	124	8	k	k	PROPN
dti-2532	124	9	,	,	PUNCT
dti-2532	124	10	et	et	PROPN
dti-2532	124	11	al	al	PROPN
dti-2532	124	12	;	;	PUNCT
dti-2532	124	13	indian	indian	ADJ
dti-2532	124	14	healthcare	healthcare	PROPN
dti-2532	124	15	associated	associate	VERB
dti-2532	124	16	infection	infection	NOUN
dti-2532	124	17	surveillance	surveillance	NOUN
dti-2532	124	18	network	network	NOUN
dti-2532	124	19	collaborators	collaborator	NOUN
dti-2532	124	20	.	.	PUNCT
dti-2532	125	1	health	health	NOUN
dti-2532	125	2	-	-	PUNCT
dti-2532	125	3	care	care	NOUN
dti-2532	125	4	-	-	PUNCT
dti-2532	125	5	associated	associate	VERB
dti-2532	125	6	bloodstream	bloodstream	NOUN
dti-2532	125	7	and	and	CCONJ
dti-2532	125	8	urinary	urinary	ADJ
dti-2532	125	9	tract	tract	NOUN
dti-2532	125	10	infections	infection	NOUN
dti-2532	125	11	in	in	ADP
dti-2532	125	12	a	a	DET
dti-2532	125	13	network	network	NOUN
dti-2532	125	14	of	of	ADP
dti-2532	125	15	hospitals	hospital	NOUN
dti-2532	125	16	in	in	ADP
dti-2532	125	17	india	india	PROPN
dti-2532	125	18	:	:	PUNCT
dti-2532	125	19	a	a	DET
dti-2532	125	20	multicentre	multicentre	NOUN
dti-2532	125	21	,	,	PUNCT
dti-2532	125	22	hospital	hospital	NOUN
dti-2532	125	23	based	base	VERB
dti-2532	125	24	,	,	PUNCT
dti-2532	125	25	prospective	prospective	ADJ
dti-2532	125	26	surveillance	surveillance	NOUN
dti-2532	125	27	study	study	NOUN
dti-2532	125	28	.	.	PUNCT
dti-2532	126	1	lancet	lancet	NOUN
dti-2532	126	2	glob	glob	PROPN
dti-2532	126	3	health	health	NOUN
dti-2532	126	4	.	.	PUNCT
dti-2532	127	1	2022;10(9):e1317	2022;10(9):e1317	NUM
dti-2532	127	2	-	-	SYM
dti-2532	127	3	e1325	e1325	PROPN
dti-2532	127	4	.	.	PROPN
dti-2532	127	5	crossref	crossref	PROPN
dti-2532	127	6	pubmed	pubmed	PROPN
dti-2532	127	7	16	16	NUM
dti-2532	127	8	.	.	PUNCT
dti-2532	128	1	veeraraghavan	veeraraghavan	PROPN
dti-2532	128	2	b	b	PROPN
dti-2532	128	3	,	,	PUNCT
dti-2532	128	4	pragasam	pragasam	PROPN
dti-2532	128	5	ak	ak	PROPN
dti-2532	128	6	,	,	PUNCT
dti-2532	128	7	ray	ray	NOUN
dti-2532	128	8	p	p	X
dti-2532	128	9	,	,	PUNCT
dti-2532	128	10	et	et	PROPN
dti-2532	128	11	al	al	PROPN
dti-2532	128	12	.	.	PUNCT
dti-2532	128	13	evaluation	evaluation	NOUN
dti-2532	128	14	of	of	ADP
dti-2532	128	15	antimicrobial	antimicrobial	ADJ
dti-2532	128	16	susceptibility	susceptibility	NOUN
dti-2532	128	17	profile	profile	NOUN
dti-2532	128	18	in	in	ADP
dti-2532	128	19	salmonella	salmonella	NOUN
dti-2532	128	20	typhi	typhi	ADJ
dti-2532	128	21	and	and	CCONJ
dti-2532	128	22	salmonella	salmonella	NOUN
dti-2532	128	23	paratyphi	paratyphi	VERB
dti-2532	128	24	a	a	PRON
dti-2532	128	25	:	:	PUNCT
dti-2532	128	26	presenting	present	VERB
dti-2532	128	27	the	the	DET
dti-2532	128	28	current	current	ADJ
dti-2532	128	29	scenario	scenario	NOUN
dti-2532	128	30	in	in	ADP
dti-2532	128	31	india	india	PROPN
dti-2532	128	32	and	and	CCONJ
dti-2532	128	33	strategy	strategy	NOUN
dti-2532	128	34	for	for	ADP
dti-2532	128	35	future	future	ADJ
dti-2532	128	36	management	management	NOUN
dti-2532	128	37	.	.	PUNCT
dti-2532	129	1	j	j	PROPN
dti-2532	129	2	infect	infect	VERB
dti-2532	129	3	dis	dis	PROPN
dti-2532	129	4	.	.	PUNCT
dti-2532	130	1	2021;224(suppl	2021;224(suppl	NUM
dti-2532	130	2	5):s502	5):s502	NUM
dti-2532	130	3	-	-	SYM
dti-2532	130	4	s516	s516	PROPN
dti-2532	130	5	.	.	PUNCT
dti-2532	131	1	crossref	crossref	PROPN
dti-2532	131	2	pubmed	pubmed	PROPN
dti-2532	131	3	17	17	NUM
dti-2532	131	4	.	.	PUNCT
dti-2532	132	1	marchello	marchello	PROPN
dti-2532	132	2	cs	cs	PROPN
dti-2532	132	3	,	,	PUNCT
dti-2532	132	4	carr	carr	PROPN
dti-2532	132	5	sd	sd	PROPN
dti-2532	132	6	,	,	PUNCT
dti-2532	132	7	crump	crump	PROPN
dti-2532	132	8	ja	ja	PROPN
dti-2532	132	9	.	.	PUNCT
dti-2532	133	1	a	a	DET
dti-2532	133	2	systematic	systematic	ADJ
dti-2532	133	3	review	review	NOUN
dti-2532	133	4	on	on	ADP
dti-2532	133	5	antimicrobial	antimicrobial	ADJ
dti-2532	133	6	resistance	resistance	NOUN
dti-2532	133	7	among	among	ADP
dti-2532	133	8	salmonella	salmonella	NOUN
dti-2532	133	9	typhi	typhi	VERB
dti-2532	133	10	worldwide	worldwide	ADV
dti-2532	133	11	.	.	PUNCT
dti-2532	134	1	am	be	AUX
dti-2532	134	2	j	j	PROPN
dti-2532	134	3	trop	trop	X
dti-2532	134	4	med	med	PROPN
dti-2532	134	5	hyg	hyg	PROPN
dti-2532	134	6	.	.	PUNCT
dti-2532	135	1	2020;103(6):2518	2020;103(6):2518	NUM
dti-2532	135	2	-	-	SYM
dti-2532	135	3	2527	2527	NUM
dti-2532	135	4	.	.	PUNCT
dti-2532	136	1	crossref	crossref	PROPN
dti-2532	136	2	pubmed	pubmed	PROPN
dti-2532	136	3	18	18	NUM
dti-2532	136	4	.	.	PUNCT
dti-2532	137	1	sharma	sharma	PROPN
dti-2532	137	2	m	m	PROPN
dti-2532	137	3	,	,	PUNCT
dti-2532	137	4	gangakhedkar	gangakhedkar	PROPN
dti-2532	137	5	rr	rr	PROPN
dti-2532	137	6	,	,	PUNCT
dti-2532	137	7	bhattacharya	bhattacharya	PROPN
dti-2532	137	8	s	s	PROPN
dti-2532	137	9	,	,	PUNCT
dti-2532	137	10	walia	walia	PROPN
dti-2532	137	11	k.	k.	PROPN
dti-2532	137	12	understanding	understand	VERB
dti-2532	137	13	complexities	complexity	NOUN
dti-2532	137	14	in	in	ADP
dti-2532	137	15	the	the	DET
dti-2532	137	16	uptake	uptake	NOUN
dti-2532	137	17	of	of	ADP
dti-2532	137	18	indigenously	indigenously	ADV
dti-2532	137	19	developed	develop	VERB
dti-2532	137	20	rapid	rapid	ADJ
dti-2532	137	21	point	point	NOUN
dti-2532	137	22	-	-	PUNCT
dti-2532	137	23	of	of	ADP
dti-2532	137	24	-	-	PUNCT
dti-2532	137	25	care	care	NOUN
dti-2532	137	26	diagnostics	diagnostic	NOUN
dti-2532	137	27	for	for	ADP
dti-2532	137	28	containment	containment	NOUN
dti-2532	137	29	of	of	ADP
dti-2532	137	30	antimicrobial	antimicrobial	ADJ
dti-2532	137	31	resistance	resistance	NOUN
dti-2532	137	32	in	in	ADP
dti-2532	137	33	india	india	PROPN
dti-2532	137	34	.	.	PUNCT
dti-2532	138	1	bmj	bmj	PROPN
dti-2532	138	2	glob	glob	NOUN
dti-2532	138	3	health	health	NOUN
dti-2532	138	4	.	.	PUNCT
dti-2532	138	5	2021	2021	NUM
dti-2532	138	6	;	;	PUNCT
dti-2532	139	1	6(9):e006628	6(9):e006628	X
dti-2532	139	2	.	.	PUNCT
dti-2532	140	1	crossref	crossref	PROPN
dti-2532	140	2	pubmed	pubmed	PROPN
dti-2532	140	3	19	19	NUM
dti-2532	140	4	.	.	PUNCT
dti-2532	141	1	van	van	PROPN
dti-2532	141	2	belkum	belkum	PROPN
dti-2532	141	3	a	a	PROPN
dti-2532	141	4	,	,	PUNCT
dti-2532	141	5	bachmann	bachmann	PROPN
dti-2532	141	6	tt	tt	PROPN
dti-2532	141	7	,	,	PUNCT
dti-2532	141	8	lüdke	lüdke	VERB
dti-2532	141	9	g	g	NOUN
dti-2532	141	10	,	,	PUNCT
dti-2532	141	11	et	et	PROPN
dti-2532	141	12	al	al	PROPN
dti-2532	141	13	;	;	PUNCT
dti-2532	141	14	jpiamr	jpiamr	VERB
dti-2532	141	15	amrrdt	amrrdt	ADV
dti-2532	141	16	working	work	VERB
dti-2532	141	17	group	group	NOUN
dti-2532	141	18	on	on	ADP
dti-2532	141	19	antimicrobial	antimicrobial	ADJ
dti-2532	141	20	resistance	resistance	NOUN
dti-2532	141	21	and	and	CCONJ
dti-2532	141	22	rapid	rapid	ADJ
dti-2532	141	23	diagnostic	diagnostic	ADJ
dti-2532	141	24	testing	testing	NOUN
dti-2532	141	25	.	.	PUNCT
dti-2532	142	1	developmental	developmental	ADJ
dti-2532	142	2	roadmap	roadmap	NOUN
dti-2532	142	3	for	for	ADP
dti-2532	142	4	antimicrobial	antimicrobial	ADJ
dti-2532	142	5	susceptibility	susceptibility	NOUN
dti-2532	142	6	testing	testing	NOUN
dti-2532	142	7	systems	system	NOUN
dti-2532	142	8	.	.	PUNCT
dti-2532	143	1	nat	nat	PROPN
dti-2532	143	2	rev	rev	PROPN
dti-2532	143	3	microbiol	microbiol	PROPN
dti-2532	143	4	.	.	PUNCT
dti-2532	144	1	2019	2019	NUM
dti-2532	144	2	;	;	PUNCT
dti-2532	144	3	17(1):51	17(1):51	NUM
dti-2532	144	4	-	-	SYM
dti-2532	144	5	62	62	NUM
dti-2532	144	6	.	.	PUNCT
dti-2532	145	1	crossref	crossref	PROPN
dti-2532	145	2	pubmed	pubmed	PROPN
dti-2532	145	3	https://wellcomecollection.org/works/thvwsuba	https://wellcomecollection.org/works/thvwsuba	PROPN
dti-2532	145	4	https://doi.org/10.1136/bmjgh-2019-002104	https://doi.org/10.1136/bmjgh-2019-002104	PUNCT
dti-2532	146	1	https://www.ncbi.nlm.nih.gov/pubmed/31799007	https://www.ncbi.nlm.nih.gov/pubmed/31799007	ADJ
dti-2532	146	2	https://doi.org/10.1016/s0140-6736(21)02724-0	https://doi.org/10.1016/s0140-6736(21)02724-0	NOUN
dti-2532	146	3	https://www.ncbi.nlm.nih.gov/pubmed/35065702	https://www.ncbi.nlm.nih.gov/pubmed/35065702	NUM
dti-2532	146	4	https://doi.org/10.1093/cid/ciy955	https://doi.org/10.1093/cid/ciy955	NOUN
dti-2532	146	5	https://www.ncbi.nlm.nih.gov/pubmed/30407501	https://www.ncbi.nlm.nih.gov/pubmed/30407501	NUM
dti-2532	146	6	https://doi.org/10.1080/14787210.2021.1951705	https://doi.org/10.1080/14787210.2021.1951705	X
dti-2532	146	7	https://www.ncbi.nlm.nih.gov/pubmed/34225545	https://www.ncbi.nlm.nih.gov/pubmed/34225545	X
dti-2532	146	8	https://doi.org/10.1371/journal.pmed.1001974	https://doi.org/10.1371/journal.pmed.1001974	X
dti-2532	146	9	https://www.ncbi.nlm.nih.gov/pubmed/26934098	https://www.ncbi.nlm.nih.gov/pubmed/26934098	NUM
dti-2532	147	1	https://main.icmr.nic.in/sites/default/files/guidelines/amrsn_annual_report_2020.pdf	https://main.icmr.nic.in/sites/default/files/guidelines/amrsn_annual_report_2020.pdf	NOUN
dti-2532	148	1	https://doi.org/10.1371/journal.pmed.1003787	https://doi.org/10.1371/journal.pmed.1003787	PROPN
dti-2532	148	2	https://www.ncbi.nlm.nih.gov/pubmed/34582466	https://www.ncbi.nlm.nih.gov/pubmed/34582466	NUM
dti-2532	148	3	https://doi.org/10.1016/s2214-109x(18)30247-x	https://doi.org/10.1016/s2214-109x(18)30247-x	NOUN
dti-2532	148	4	https://www.ncbi.nlm.nih.gov/pubmed/29903376	https://www.ncbi.nlm.nih.gov/pubmed/29903376	NOUN
dti-2532	148	5	https://doi.org/10.1371/journal.pone.0180705	https://doi.org/10.1371/journal.pone.0180705	NOUN
dti-2532	148	6	https://www.ncbi.nlm.nih.gov/pubmed/29953451	https://www.ncbi.nlm.nih.gov/pubmed/29953451	ADP
dti-2532	148	7	https://doi.org/10.1186/s13756-021-00931-w	https://doi.org/10.1186/s13756-021-00931-w	NOUN
dti-2532	148	8	https://www.ncbi.nlm.nih.gov/pubmed/33789754	https://www.ncbi.nlm.nih.gov/pubmed/33789754	PRON
dti-2532	148	9	https://doi.org/10.4103/0976-9668.116970	https://doi.org/10.4103/0976-9668.116970	PROPN
dti-2532	148	10	https://www.ncbi.nlm.nih.gov/pubmed/24082718	https://www.ncbi.nlm.nih.gov/pubmed/24082718	NUM
dti-2532	148	11	https://doi.org/10.1016/j.ajic.2017.06.028	https://doi.org/10.1016/j.ajic.2017.06.028	PROPN
dti-2532	148	12	https://www.ncbi.nlm.nih.gov/pubmed/28807425	https://www.ncbi.nlm.nih.gov/pubmed/28807425	NUM
dti-2532	148	13	https://doi.org/10.1016/j.jiph.2021.12.008	https://doi.org/10.1016/j.jiph.2021.12.008	NOUN
dti-2532	148	14	https://www.ncbi.nlm.nih.gov/pubmed/34972026	https://www.ncbi.nlm.nih.gov/pubmed/34972026	NOUN
dti-2532	148	15	https://doi.org/10.1016/s2214-109x(22)00274-1	https://doi.org/10.1016/s2214-109x(22)00274-1	NOUN
dti-2532	148	16	https://www.ncbi.nlm.nih.gov/pubmed/35961355	https://www.ncbi.nlm.nih.gov/pubmed/35961355	NUM
dti-2532	148	17	https://doi.org/10.1093/infdis/jiab144	https://doi.org/10.1093/infdis/jiab144	NOUN
dti-2532	148	18	https://www.ncbi.nlm.nih.gov/pubmed/35238369	https://www.ncbi.nlm.nih.gov/pubmed/35238369	PRON
dti-2532	149	1	https://doi.org/10.4269/ajtmh.20-0258	https://doi.org/10.4269/ajtmh.20-0258	PROPN
dti-2532	149	2	https://www.ncbi.nlm.nih.gov/pubmed/32996447	https://www.ncbi.nlm.nih.gov/pubmed/32996447	PROPN
dti-2532	149	3	https://doi.org/10.1136/bmjgh-2021-006628	https://doi.org/10.1136/bmjgh-2021-006628	PROPN
dti-2532	149	4	https://www.ncbi.nlm.nih.gov/pubmed/34580070	https://www.ncbi.nlm.nih.gov/pubmed/34580070	ADV
dti-2532	149	5	https://doi.org/10.1038/s41579-018-0098-9	https://doi.org/10.1038/s41579-018-0098-9	NOUN
dti-2532	149	6	https://www.ncbi.nlm.nih.gov/pubmed/30333569	https://www.ncbi.nlm.nih.gov/pubmed/30333569	PUNCT